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Thesis Abstract 
Cancer can have major implications for those who receive a diagnosis, not only as a 
result of its physical impact, but its emotional one.  The emotional impact can not only be 
distressing in itself, it can also affect behaviour and therefore, has been linked to poorer 
treatment adherence. 
The experience of difficult self-directed emotions, such as guilt, shame and disgust 
have provoked particular interest, particularly due to their association with rejection and 
avoidance.  Therefore, insight into how and when these emotions are experienced within the 
cancer treatment journey are important to understand, in order that optimum support can be 
provided. 
The first paper is a thematic synthesis that explores the emotional experiences of people 
undergoing cancer treatment with a curative intent. The synthesis is structured by a sequential 
framework of four key transition points within the cancer journey, and the emotional 
experiences synthesised within each one.  The temporal transition points were: Being 
diagnosed and facing treatment; Getting rid of cancer; Changed body and stigma; Reflections 
on the emotional journey having completed treatment.  The synthesis demonstrates how 
emotions and feelings evolve and change in type, frequency and intensity across the curative 
cancer journey.  
The second study uses narrative analysis methodology to explore difficult self-directed 
emotions throughout cancer treatment and into recovery.  The analysis focuses on how and 
when the emotions of disgust, guilt, shame and fear arise, as well as resulting changes to the 
sense of self.  The findings demonstrate how many factors, such as relationships, current 
stressors, past experiences and resources (personal and systemic) can impact on emotional 
experiences.  The critical appraisal focuses on strengths and weaknesses of the studies, 
particularly in relational to emotional research considerations more generally. 
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Abstract 
Aim: In an attempt to understand the emotional experience of people undertaking cancer 
treatment (regardless of any formal ‘mood’ diagnosis), a qualitative synthesis was 
undertaken.   
Method: The search strategy was designed to include international research from the 
perspective of the individual undergoing treatment - from cancer diagnosis to the completion 
of curative treatment, including adjuvant therapy.  The thematic synthesis was conducted 
according to the framework set out by Thomas and Harden (2008).   
Findings: The search strategy yielded an initial set of 7,093 papers from which, after the 
inclusion and exclusion criteria were applied, 12 were retained for analysis.  The analysis 
produced four temporally organised themes that spanned a diverse range of cancer 
experiences: Being diagnosed and facing treatment; Getting rid of cancer; Changed body and 
stigma; Reflections on the emotional journey having completed treatment.   
Discussion: The synthesis demonstrated how emotional experiences are related to coping 
strategies and ultimately the adoption of new identities.  Social comparisons were used in 
order to gain and maintain hope and to cope.  However, gender differences in how emotional 
experience was expressed and acted upon were also illustrated.  The findings are discussed in 
relation to the complexity of emotions and how they evolve across the cancer treatment 
journey.  
 
 
Keywords:  Cancer, Emotions, Experiences, Thematic Synthesis 
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It is predicted that by 2035 approximately 24 million people worldwide will have had 
a cancer diagnosis (World Cancer Research Fund International, 2016).  Despite the increase 
in the number of people receiving a diagnosis of cancer, mortality rates are falling.  This 
trend can particularly be seen in countries such as the United Kingdom where there have been 
significant advancements in detection and treatments (Office for National Statistics, 2015).   
However, regardless of increasing survival rates, cancer remains a life-threatening illness 
affecting people not only physically, through the disease process and treatment effects, but 
emotionally, throughout the cancer journey.  
Many studies have been undertaken to explore specific aspects of having cancer, for 
example, the experience of being diagnosed with a particular type of cancer at certain stages, 
such as advanced lung cancer (Dickerson et al., 2012).  Other studies have focused on the 
experiences of cancer diagnosis from a cultural (Ashing-Giwa et al., 2004) or family relative 
perspective (Olson, 2011), and demonstrate the emotional impact of cancer.  Moreover, 
studies that have concentrated on the experience of undergoing specific cancer treatments, 
such as chemotherapy (Bernhardson, Tishelman, & Rutqvist, 2007) or focused on the 
treatment of side-effects such as alopecia (Williams, Wood, & Cunningham-Warburton, 
1999), demonstrate a wide array of emotional experience.  Furthermore, a number of studies 
have focused on the emotional experiences across the whole cancer treatment journey with 
curative intent. 
Theoretically, it has been proposed that there are six emotions (happiness, fear, anger, 
sadness, disgust, sadness and surprise) (Ekman, 1992), with all other emotions considered to 
be a combination of these basic emotions (Plutchik, Kellerman, & Conte, 1979).  Feelings, 
however, although considered closely related to emotions, differ from them on the basis of 
being mental associations to emotions that are autobiographical and influenced by personal 
experiences and beliefs (Damasio, 1999).  The term affect is often used to describe the 
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experience of feeling or emotion (VandenBos, 2007).  Lay understandings of the ‘emotional’ 
experiences of being diagnosed with cancer and receiving treatment may incorporate both or 
a combination of different affective experiences throughout the treatment journey.  In this 
regard, the term emotional experiences in this review is more encompassing and is used to 
describe not just emotions but feelings, which encompass personal appraisals and labels 
(Shouse, 2005).  Using this broad definition of ‘emotional experience’ means that all personal 
affective experiences (emotions and feelings), such as emotional distress and problems are 
included with the analysis.   
The interest in emotional experiences is in part due to the frequency of emotional 
difficulties experienced by people with a cancer diagnosis.  For example, one study in North 
America estimated the prevalence of emotional distress to be 35.1% overall (Zabora, 
BrintzenhofeSzoc, Curbow, Hooker, & Piantadosi, 2001), with similar rates reported in 
Europe, Asia and the Middle East (Bultz & Carlson, 2005).  These high prevalence rates of 
distress experienced within the cancer journey have led to emotional distress being 
considered  by some cancer researchers as ‘the sixth vital sign in cancer care’ (Bultz & 
Carlson, 2005, p. 1).    
Emotional distress is associated with increased costs in cancer treatment care, due to a 
documented relationship between distress and treatment adherence.  For example, a 
systematic review of psychosocial treatments for emotional distress in cancer concluded that 
large reductions in medical costs (from general practitioner and specialist visits) could result 
from treating ‘emotional problems’ (Carlson & Bultz, 2003).  Emotional distress, such as 
anxiety symptoms have also been found to predict reductions in chemotherapy adherence 
(Greer, Pirl, Park, Lynch, & Temel, 2008). 
A focus on emotional distress and its consequences has been responsible for shaping 
guidance on the identification and subsequent interventions for these types of emotions 
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during cancer treatment (National Cancer Control Initiative, 2002; National Institute for 
Health and Clinical Excellence, 2004; World Health Organization, 2002).  The underlying 
assumptions of emotional distress are that these experiences are negative.  As a result, the 
guidance is focused on the management of distress, viewing it as requiring early 
identification and intervention from the point of diagnosis and throughout the treatment 
journey. 
However, the assumption that the experience of distress is purely negative, and 
therefore needs treating, is not unchallenged.  For example, a study which adopted a 
qualitative methodology to understand emotional distress soon after a cancer diagnosis 
demonstrated that attempting to engage people psychologically, early in their cancer journey, 
may not only be unhelpful but may disrupt their own individual styles of coping (Baker et al., 
2013).  Moreover, some evidence suggests that experiencing emotional distress can actually 
be of benefit, with some studies finding that early emotional distress can be indicative of 
‘positive adjustment’ later in the cancer journey (Arman, Rehnsfeldt, Lindholm, Hamrin, & 
Eriksson, 2004; Horgan, Holcombe, & Salmon, 2011).  Similarly, some evidence has 
indicated that emotional suppression soon after cancer diagnosis is linked to increased 
distress and ‘poorer adjustment’ in the future (Iwamitsu et al., 2003; Stanton et al., 2000).  
Therefore, emotional distress during cancer treatment requires more complex interpretations 
and understanding than viewing the experience through an inherently undesirable lens. 
In contrast to the distress narrative that dominates much of the empirical and grey 
(unpublished or published non-commercially) literature, positive emotional and 
psychological changes have also been demonstrated as part of the cancer journey.  Some of 
this research focuses on psychological well-being within the cancer journey as measured 
through the absence of negative affective experiences, for example, depression (Kissane et 
al., 2004), anxiety (Segrin, Badger, Dorros, Meek, & Lopez, 2007) and trauma (Cordova et 
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al., 2007) symptoms.  However, some studies have also demonstrated positive affective 
changes throughout the cancer journey, such as, after diagnosis (Horgan et al., 2011) and in 
the late-stages (Rabkin, McElhiney, Moran, Acree, & Folkman, 2009).  For example, a 
qualitative review of 57 studies (35 of which focused on cancer) assessing post-traumatic 
growth in life threatening illness (Hefferon, Grealy, & Mutrie, 2009) found positive longer 
term changes as a result of having this type of illness.  The review demonstrated that people 
re-evaluated their relationships, leading to closer and more open relationships with close 
family and friends, had less interest in appearance and monetary wealth and experienced a 
change in life goals.  Many people also gained a sense of physical power and potency and 
reconnection of the body and mind.   
Many policies and protocols within the area of distress management rely on health 
professionals to undertake screenings at time points within the cancer treatment journey.  
However, some studies have indicated that the understanding of events that cause distress 
differs between health professionals and people with cancer.  For example, a qualitative study 
sought to identify events that caused distress in women with breast cancer and compared 
these with physician expectations of events to cause distress.  Although there was 
concordance in some events, such as diagnosis, many women expressed distress at the side-
effects of treatment and problems with prosthesis after mastectomy, which were not reflected 
in physicians’ expectations (Jones & Greenwood, 1994).   
To attempt to understand the emotional experience from the perspective of the person 
undertaking cancer treatment (regardless of emotion/mood classifications) - a methodology 
that can capture the complex nature of the emotional experience of the cancer journey is 
required.  Qualitative studies can uncover emotions and meaning and explain the processes of 
emotional change that may be experienced within the cancer treatment journey (Dixon-
Woods, Fitzpatrick, & Roberts, 2001).  Thematic synthesis is a method by which a body of 
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qualitative studies can be drawn upon in order to offer an understanding of a given 
experience (Thomas & Harden, 2008) - in this case the emotional experiences within the 
cancer treatment journey.  Thus, thematic synthesis is an approach that can provide a broad 
description by drawing on many themes from which interpretative constructions and 
understandings of emotional experience of the curative cancer treatment journey can be 
formed.  Thematic-synthesis can also be conducted from a critical realist stance, in which the 
possibility of objective knowledge or reality is accepted, while maintaining that many 
different meanings and interpretations of a phenomenon can co-exist (Barnett-Page & 
Thomas, 2009).  Furthermore, qualitative research is becoming more and more utilised in 
health settings, with health professionals incorporating findings from these studies into their 
practice (Miller, 2010).   
 
Method 
Identification of Published Work 
In October 2016, a systematic literature search was performed across PsycINFO, 
CINAHL (Cumulative Index to Nursing and Allied Health Literature), PubMed and Web of 
Science.  The PsycINFO, CINAHL and PubMed databases provide good coverage of the 
subject matter and have been used in previous reviews that focused on the experience of 
cancer (e.g., Smith, Pope, & Botha, 2005; LeSeure & Chongkham-ang, 2015).  In addition, 
Web of Science was included as it provides a broad subject search that includes health and 
medicine, social sciences and arts and humanities potentially relevant to this thematic 
synthesis. Guidance and advice on the search strategy was sought and provided by an 
academic librarian from Lancaster University.   
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The review included papers from peer-reviewed journals and those which met the 
inclusion and exclusion criteria (LeSeure and Chongkham-ang, 2015, was also used for 
guidance): 
1.  Studies that were based on a population of adult participants 18 years or older when 
diagnosed with cancer. 
2. Studies that focused on emotional experiences from diagnosis through to completion 
of active curative treatment. 
3. Studies in which the researcher(s) obtained and presented interview data from people 
with a cancer diagnosis separately from any other samples included in the research paper. 
4. Data based on the emotional experience of cancer patients were presented. 
5. Studies that used qualitative content-based (as opposed to discourse-based) 
methodologies for data analysis.  
6. Mixed-design studies which separately analysed and presented qualitative findings 
from quantitative data and used content-based approaches such as grounded theory, 
interpretative phenomenological analysis, hermeneutics, thematic analysis, content analysis 
and narrative analysis.  
Studies were excluded if: 
1.   The population within the study were no longer undergoing curative treatment, such 
as terminally ill patients, or those receiving end-of-life care, or those only receiving 
supportive treatment, as this was considered a qualitatively different experience from curative 
treatment (LeSeure & Chongkham-ang, 2015).  
2.  Studies that focused on specific experiences of cancer, as the full emotional 
experience from across the cancer treatment journey could not be illustrated.  Specific 
experiences included a focus on symptoms, such as cancer related pain (e.g. Boström, Sandh, 
Lundberg, & Fridlund, 2004) or lymphedema, (e.g. Johansson et al., 2003) or specific cancer 
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treatment experiences, such as chemotherapy (e.g. Bernhardson et al., 2007), or cancer 
related inventions, such as, relaxation (e.g  Adamsen, Stage, Laursen, Rørth, & Quist, 2012) 
or psychoeducation (e.g. Edelman, Craig, & Kidman, 2000). 
3. Papers that focused on phases before or after cancer treatment, such as survivorship or 
screening. 
4. Studies that focused predominantly on relationships or sexual well-being of cancer 
patients, or focused on aspects of communication. 
5. Papers that focused on one experience within the cancer treatment journey, such as 
diagnosis or hope, as the focus was not on the breadth of emotions spanning the treatment 
journey. 
6. Papers that did not support themes with direct quotations. 
7. Studies that did not use an established qualitative design. 
8. Reviews and editorials, as per Smith et al. (2005). 
9. Due to difficulties in the translation of ‘meaning’ across languages, non-English 
language papers were excluded (Temple, 2006). 
Search terms were generated using past literature reviews within the cancer research 
domain (LeSeure & Chongkham-ang, 2015).  MESH or thesaurus headings were exploded 
when possible and subject headings incorporated.  Where possible, a methodology filter was 
applied (Search Filter for Databases, The University of Texas, 2016).  When this was not 
possible, specificity filters for methodology within the search engine were applied (see 
Appendix A for exact terms input for each database search).  The search terms used were 
‘neoplasms’ OR ‘oncology’ OR ‘cancer’ AND ‘emotion*’ OR experience*’ OR  
‘perception*’  AND ‘individual*’ OR ‘client*’ OR ‘ patient*’ OR ‘cancer patients’ AND 
‘interviews’  OR ‘focus groups’ OR ‘narration’ OR qualitative research OR’ semi-structured’ 
OR ‘semistructured’ OR ‘unstructured’ OR ‘structured’ OR ‘informal’ OR ‘in-depth’ OR 
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‘indepth’ OR ‘face-to-face’ OR ‘guide’ OR ‘guides’ AND ‘interview*’ OR ‘discussion*’ OR 
‘questionnaire*’ OR ‘focus group’ OR ‘focus groups’ OR ‘qualitative’ OR ‘ethnograph*’ OR  
‘fieldwork’ OR ‘field work’ OR ‘key informant’. 
Selected studies 
The details of how the identified papers were included in the thematic synthesis are 
contained within Figure 1.  From the search strategy, 12 papers were identified that met the 
terms of criteria and are detailed in Table I. 
[INSERT FIGURE 1 HERE] 
[INSERT TABLE 1 HERE] 
Characteristics of the selected studies 
The 12 identified studies were published between 2000 and 2016.  Of these, six used 
European samples (3 in the United Kingdom, 2 in Sweden, 1 in Finland).  Two studies used 
Australian samples, two used US samples, and two used a sample based in Iran.  The sample 
size used within the studies ranged from 5 to 45.  The mental health status of participants was 
not indicated in the studies reviewed. 
All the papers used a content-based qualitative analysis to analyse the data.  Three 
used a thematic analysis method, three used content analysis, four used a phenomenological 
approach, one a hermeneutic method and one employed grounded theory.   
Nine papers used face-to-face interviews for data collection, with two studies (Oster, 
Hedestig, Johansson, Klingstedt, & Lindh, 2013; White-Means et al., 2015) using focus 
groups.  One study used semi-structured written narratives across two time points, one week 
and three months post-yoga intervention (Leal et al., 2015).  Although the exact length of 
time elapsed since cancer diagnosis and the completion of treatment was not always clear, the 
stage within the treatment journey was able to be ascertained by careful reading of the 
analysis and participant quotations provided.  All papers focused on experiences from 
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diagnosis through to treatment as a minimum, but as a set of papers the interviews covered 
experiences that ranged from pre-diagnosis through to convalescence following treatment. 
Appraising the quality of reporting of the selected studies 
 The strengths and weaknesses of reporting for each study were considered using the 
CASP checklist of qualitative studies (Critical Appraisal Skills Programme, 2017).  The 
initial items in the checklist related to whether there was a clear statement of the research 
aims and if a qualitative methodology was an appropriate approach given the intended aims.  
All the selected studies met these criteria.  Each paper was then evaluated by the researcher 
across the remaining eight items on the qualitative study checklist.  A three point system was 
used for each of the eight checklist items which generated a score for each component 
(Duggleby et al., 2010).  Scores between one and three corresponded with whether the 
reporting for the area was considered weak, moderate or strong.  A total for reporting 
strength, out of a possible 24, was then generated for each paper (see Table II).   
[INSERT TABLE 2 HERE] 
Analysing and synthesizing the data 
 Qualitative synthesis is valued, particularly within health research, for its 
ability to offer explanations for qualitative study findings.  However, how the quality of the 
studies used in qualitative reviews is assessed and even if quality assessment offers any utility 
is still debated, particularly when considering study quality in review exclusion versus 
inclusion criteria (Dixon-Woods et al., 2001).   Furthermore, some researchers in the field of 
health research have opted to use an entirely inclusive approach.  The rationale for this type 
of approach has been based on previous experience of using such tools as the Critical 
Appraisal Skills Programme (CASP), coupled with the argument that papers used in the 
subsequent review should be judged on how much they contribute to the synthesis question 
(Smith et al., 2005).  In this respect, Thomas and Harden (2008) offer an approach to 
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synthesising qualitative studies that discourages preconceptions of objectivity, instead 
highlighting subjectivity, and therefore can be seen as an interpretative, as opposed to an 
aggregative, approach.  For the purpose of this review, CASP was used in order to highlight 
the quality of reporting, however it was not used to exclude papers from the review. 
 This thematic-synthesis utilised a seven-phase approach that incorporated Thomas and 
Harden (2008) three stage synthesis.  The initial phase involved finding a review question 
that incorporates both the intellectual interest of the researcher and requires a strategy by 
which ‘how’ or ‘why’ questions could be answered.  The subsequent phase involved making 
decisions around what was relevant in order to answer the question.  Particular to this 
synthesis, studies that focused on people who were undergoing a curative cancer treatment 
journey were relevant, therefore the studies of interest for comparison needed to involve 
perspectives from people with this particular lived experience and foregoing other 
experiences, such as those of care-givers.  Applying particular inclusion and exclusion 
criteria avoided the synthesis becoming too generalised and ensured an original account.   
The analysis of the identified data for synthesis began in the third phase by reading 
and re-reading the selected accounts, drawing on the details held within findings or results 
sections of studies and how they related to the research question.  The data included themes, 
interpretations, sentences and participant quotes that related to emotional experience (see 
Appendix B, for a sample data extraction table).   In particular, the focus was on emotional 
experience, in relation to what these experiences were and the points at which they were 
being experienced within the cancer treatment journey.  Leading on from this, the fourth 
phase of the analysis began to bring together findings from across studies, by creating a list of 
emotions and when they occurred.  As a result, a thematic analysis was formed and initial 
assumptions of how individual studies related to each other began to be identified and 
developed.  During this phase, it was noted that many themes across the studies fell into 
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temporal or sequential sections that acted as transition points within the curative cancer 
treatment journey.  In fact six of the studies themes were ordered sequentially as the cancer 
treatment trajectory unfolded (Hu, Cooke, & McCarthy, 2009; Papadopoulou, Johnston, & 
Themessl-Huber, 2016; Taleghani, Yekta, Nasrabadi, & Kappeli, 2008; White-Means, Rice, 
Dapremont, Davis, & Martin, 2015; Winterbottom & Harcourt. 2004; Xuereb & Dunlop, 
2003).   At this point a general sequential framework was adopted in order that emotional 
themes from each of these transition points within the journey could be illustrated. (Heiland 
et al., 2008) 
Phase five involved translating the central emotional experience of each account and 
their interactions, and comparing them to the accounts and interactions across the studies, 
within each part of the treatment experience.  Particular attention was given to data diversions 
within the themes.  How well the concepts incorporated the themes from the original studies 
was evaluated and adjustments made in order to capture the accounts from each paper (see 
Appendix C, for a sample of a grouped concept).  
Translation of the studies then led to synthesis in phase six.   The synthesis phase 
involved answering the review question with analytical themes created utilising the emerged 
themes from the inductive analysis of studies.  The analytical themes capture a key concept or 
‘line of argument’ (Thomas & Harden, 2008, p.7) related to the review question and from 
which recommendations can be generated.  The contribution per paper towards the themes 
was noted (see Table. III). 
The final phase of the analysis was concerned with how synthesis was expressed.  In 
this regard the synthesis needed to be understood, while being meaningful.  Moreover, the 
synthesis needed to stretch the insight of its intended audience, by presenting the views and 
perspectives of those experiencing the cancer treatment journey. 
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The data were analysed based on critical realist epistemology, in that the analysis 
accepted that it is possible to know individual perspective, as thoughts, feelings and 
experiences are reflected in the language of the participant. 
[INSERT TABLE 3 HERE] 
 
Findings 
The thematic synthesis concerns the emotional experiences within these four temporal 
themes: Being diagnosed with cancer and facing treatment; Getting rid of cancer; Changed 
body and stigma; Reflections on the emotional journey having completed treatment.   
Being diagnosed with cancer and facing treatment 
The emotions experienced at the point of being diagnosed with cancer were wide 
ranging and included fear, worry, hope, sadness, disappointment and uncertainty.  These 
mixed feelings were typically experienced in quick succession and changed rapidly: 
‘Everything was chaotic, and I didn’t have one clear thought in my head’ (Ekman, Bergbom, 
Ekman, Berthold, & Mahsneh, 2004, p. 179).  All studies with the exception of one (Joulaee, 
Joolaee, Kadivar, & Hajibabaee, 2012) reported that shock was the initial reaction to 
receiving a diagnosis of cancer, despite participants experiencing bodily symptoms consistent 
with a potential diagnosis.    
Feelings of fear and worry were demonstrated in all papers; in particular these 
feelings were related to the potential threat to life that a cancer diagnosis posed and 
highlighted visceral responses: ‘I felt like my guts had been ripped-out. I was going to die 
and I was definitely not ready for it.’ (Leal et al., 2015, p. 141).  This physical response to 
diagnosis vividly indicates the depth and intensity of the emotions experienced at this time. 
However, two papers noted that whether and how people had been previously exposed to 
cancer, appeared to influence the perception of cancer as a ‘death sentence’ (Ekman et al., 
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2004; Winterbottom & Harcourt, 2004).   Participants who had previous experience or 
knowledge of cancer saw their tumour as a disease that could be treated:     
Um…obviously when they told me it was cancer, the big ‘C’ word, it was scary…but 
I was still quite calm, because I was told that it was 0.6 mm. And if it’s over 1 mm, 
that’s when it’s got the potential to spread. So I was still quite calm and I thought, ‘Oh 
well, you know, we’ve caught it early enough, I’m not too worried’. (Winterbottom & 
Harcourt, 2003, p. 230) 
After the initial shock, previous experiences of cancer survival led to more readily 
expecting a cancer diagnosis with bodily signs such as ‘hard belly’ or urinary incontinence 
being viewed as potential indicators of cancer.  Furthermore, some participants reported that 
they had strong thoughts and feelings connected with cancer, such as feeling like there was a 
‘spider in the body’ before receiving a cancer diagnosis.  These thoughts and feelings 
indicated the emotion of disgust resulting from the feeling contaminated by the harbouring of 
the unwelcomed cancer.  Both these scenarios offered some buffering against the shock and 
surprise of receiving a cancer diagnosis ‘So it was not a big surprise.  In some strange way I 
knew what it was’. (Ekman et al., 2004, p. 179).   
In contrast, those informants who had no previous experience of cancer and therefore 
were reliant on dominant perceptions of cancer, or those who had negative cancer 
experiences, such as cancer leading to the death of a close relative, friend or spouse, tended to 
think of their diagnosis as a death sentence.  Those people who felt their diagnosis was 
potentially ‘the end’, experienced fear, panic, distress and turmoil, which one participant 
expressed as a ‘special kind of anxiety’ (Taleghani et al., 2008, p. E35).  Experiencing these 
emotions for some led to expressions of needing to feel ‘strong’ indicating defiance and a 
need for courage, in order to fight their cancer and alleviate the threat to life.  Experiences of 
needing to feel strong and preparedness to fight by getting on with the treatment was reported 
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in four papers.  One participant expressed this as ‘attack mode’ leading to a desire for 
immediate action, asking ‘How soon can we get it out?’ and expressing that ‘If I could’ve had 
my surgery the next day, I would have’ (White-Means et al., 2015, p. 10).  Moreover, there 
was a need to escape as a response to the emotional turmoil of receiving a cancer diagnosis:   
I felt like I had done a crime and I was waiting for the verdict to be handed in . . . I did 
contemplate suicide . . . and it is only my strong maternal instinct that kept saying ‘no, 
it was more heroic to die of cancer than going under a train’. (Xuereb & Dunlop, 
2003, p. 401). 
Both expressions of needing to fight or to escape were responses to the emotional experience 
of receiving a potentially life threatening diagnosis.  Both offered attempts to gain some 
sense of control during a time of uncertainty.  
Furthermore, social comparisons were used as a way of gaining a more positive 
perspective on the diagnosis, by concluding that the situation could have been much worse.  
This was demonstrated in three papers: ‘I just thought, you know, it is one of those things, 
that it’s been noticed and it’s being treated’ (Winterbottom & Harcourt, 2004, p. 230).  
Moreover, concern over the impact of the cancer diagnosis on family members, was 
prioritised over personal emotional distress in seven studies: ‘It’s better they don’t worry I 
mean the wife and the children, too’ (Vaartio, Kiviniemi, & Suominen, 2003, p. 184).  The 
possibility of dying led to concern for important people in participants’ lives:  ‘The only thing 
that went through my head was “I will not see my beautiful daughter walk down the aisle”.  
There was no concern for me, that was one thing I wanted to fulfil.’ (Xuereb & Dunlop, 
2003, p. 400). 
 Waiting for cancer treatment, treatment procedures and the treatments themselves 
elicited many different emotional experiences.  However, a common factor was the urge to 
want to rid the body of cancer as soon as possible.  Cancer was viewed as a dangerous 
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contaminant within the body that posed a greater threat the longer it remained there: ‘Cancer 
is something ‘evil’ that should be removed from the body’ (Ekman et al., 2004, p. 179).  
Therefore waiting for cancer treatment to begin was a difficult period with much uncertainty.  
However, once arrangements for active treatment began, feelings of hope and an impetus to 
defy cancer emerged: ‘Up until I had the transplant there was no hope, and without any hope 
I didn’t have anything to really work towards. But once I started to get some hope, you know, 
the fight began.’ (Xuereb & Dunlop, 2003, p.  404).   
 In contrast, some cancer journeys that involved treatment immediately after diagnosis, 
such as that for people with malignant melanoma (White-Means et al., 2015), did not involve 
a period of waiting.  However, feelings of gratitude, relief and happiness that treatment 
swiftly followed diagnosis, along with empathy for how difficult waiting may have been, 
were expressed: 
I think I am a bit of a coward myself, and if I would have had to go home and wait I 
am not quite sure whether I would have made it back.  So I am glad that it was done 
on the day. (Winterbottom & Harcourt, 2004, p. 231). 
 A common response to uncertainty while waiting for treatment to begin was to 
attempt to prepare for all eventualities, including the prospect of leaving loved ones behind. 
Some used this waiting time to ‘get their house in order’ (France et al., 2000, p. 344), making 
legal and practical arrangements in order to alleviate concerns for family members. The 
responses adopted to the uncertainty and worry experienced during this period of waiting 
helped participants gain some sense of control at a time when treatment progress was in the 
hands of others. 
Getting rid of cancer 
 The wide variation in treatment processes elicited many emotional experiences in 
those undertaking them, from fear that the treatment would be difficult and potentially 
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unsuccessful, versus the hope that it would rid the body of cancer and lead to a cure.  
However, much of the action towards a cure was in the hands of clinicians and is therefore 
reliant on trusting empowered professionals.  In order to manage the distress caused by 
finding themselves in a disempowered situation, different strategies were used.  Some 
managed this distress by finding reassurance in the skills of the surgeon and even, where 
possible, choosing their surgeon.  
 In contrast, the experience of being in the hands of others left some feeling coerced 
and lacking a sense of control or agency during exposing medical procedures.  ‘. . . and they 
took that prostate and fired eight shots at me. Oh, oh, that was not good, I think.’ ‘[It was 
like] . . . rape.’ (Oster et al., 2013, p. 334).  ‘They took’ as well as ‘rape’ indicates an enemy 
analogy, with the health professions undertaking the treatment in a position of power and 
control.  The word ‘rape’ also suggests violation and its use within this context may be a 
projection of the original violation of cancer.  Others found that a lack of control and distress 
stemmed from the ‘foreignness’ of the hospital culture, being part of an unfamiliar system at 
a time of vulnerability and when feeling anxious: ‘Cancer and treatments are usually foreign 
situations to deal with, and people assume that you know more than you do, or that someone 
else has talked to you, it makes it even more difficult.’ (Leal et al., 2015, p. 142). 
 Furthermore, the hospital stays during curative treatment served as both a source of 
comfort and distress.  Some experienced the hospital environment as a signal of hope for the 
future, seeing it as a place of security.  However, particularly for those facing extended 
hospital stays due to the nature of their treatment, such as transplant patients, the restrictions 
placed on them were sources of distress.  One participant likened the experience to 
imprisonment: ‘Feels like a trapped insect trying to find its way out by crawling up the walls 
of confinement to freedom’.  (Papadopoulou et al., 2016, p. E76). 
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 Moreover, medical professionals were viewed by some participants as a potential 
source of comfort and reassurance, particularly when experiencing difficult emotions such as 
embarrassment or fear. Calm talk and sharing experiences of recovery were viewed as 
positive responses by professionals to the difficult emotional experiences of people 
undergoing treatment.  In contrast, feelings of fear and distress could also be enhanced if 
medical staff in control, did not acknowledge or attend to them, particularly when undergoing 
medical procedures and attempting to respond to instructions.  
Because I thought, ‘can’t they see how hard this is? This is really, really hard’. When 
you’re feeling so bad . . . they were actually trying to do me a favour, but maybe they 
didn’t understand the level of effort I was making.  (Xuereb & Dunlop, 2003, p. 404). 
Adjuvant therapy, such as chemotherapy, could elicit strong emotions, particularly 
when many of the side-effects induced physical and psychology changes.  For some, 
particularly those for whom their cancer had remained invisible, due to little change to the 
body envelope as a result of surgery or few symptoms prior to treatment, bodily changes as a 
result of chemotherapy could result in cancer feeling closer or more real than before.  The 
side-effects of chemotherapy were lengthy and typically involved: fatigue, hair loss, nausea, 
vomiting, heartburn, and stomach pain, often coupled with anxious feelings.  A common 
theme resulting from receiving chemotherapy was that this was the most difficult part of the 
cancer treatment journey to manage: ‘The treatment they give me, it is barbaric. Cause I was 
so sick . . . I knew it was going to be bad, but I didn’t realise how bad it was’. (Xuereb & 
Dunlop, 2003, p. 404).    This part of the treatment journey, particular as a result of fatigue, 
could lead to feeling low and not in control:  ‘You kind of get depressed or something and 
you just want to lie there and sleep to get rid of it.’  (Vaartio et al., 2003, p. 185) 
 However, although the side-effects of the treatment had a negative impact, both 
physically and psychologically, the enormity of the changes resulting from chemotherapy 
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could elicit feelings of hope.  Chemotherapy could be viewed as a ‘good poison’ that could 
‘cleanse’ the body of cancer: ‘It must be something very strong in the medicines in that you 
feel so sick, but it will surely take away the cancer cells.’ (Ekman et al., 2004, p. 179). 
 In comparison to chemotherapy, radiotherapy resulted in fewer side-effects due the 
nature of the treatment.  However, strong emotions about the therapy were particularly salient 
at the time that the treatment was administered.  These emotional experiences included 
embarrassment and feeling unsafe.  In particular, the process of being examined in order for 
the radiotherapy to be correctly aligned to the target area was considered embarrassing.  The 
treatment then requires that the person undertaking the therapy remain completely still and 
alone for number of minutes.  This experience was often accompanied with feelings of 
uncertainty and isolation: 
The first time when I was lying there I felt excluded [from knowing what was 
happening] . . . preferably you would like to see it [the radiation equipment], pick it to 
pieces, oh . . . that would alleviate the pressure of that feeling of not knowing.  (Oster 
et al, 2013, p. 334). 
However, a sense of hope and feeling lucky to have therapy that would lead to recovery was 
also felt at this time. 
Changed body and stigma 
 As a result of some surgical treatments, the body was affected.  Commonly, changes 
to the body envelope caused a huge amount of distress.  The impact of changed body image 
had the capability of penetrating many areas of the person’s life, including intimate 
relationships, career and social life.  More notably, change in more visible areas, such as the 
face, had a greater emotional impact than less visible areas.  In particularly, fear of 
discrimination and rejection as a result of altered appearance were apparent: ‘…being treated 
with discrimination, being rejected, and sarcasm and spite were inevitable.’ (Hu et al., 2009, 
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p. 329).  Moreover, less visible changes in the body envelope, such as male mastectomies, 
could also lead to embarrassment and fear of judgement: ‘I don’t think I’ll be stripping off 
this year… and if you wear a tight shirt you’re lopsided.’ (France et al., 2000, p. 345).   In 
particular, breast cancer, which is more associated with women, was a source of stigma for 
men who had contracted this type of cancer.  Men found conversations about their diagnosis 
and treatment with friends and family difficult, as it was often assumed that breast cancer was 
a ‘women’s problem’:  ‘I could have talked to other people but they actually feel embarrassed 
because it is seen as a woman’s complaint, it’s daft for a bloke to have breast cancer’ (France 
et al., 2000, p. 345). 
 In contrast, men who experienced cancer associated with men, such as prostate 
cancer, found it easier to be open about their cancer and the side-effects of treatment: 
‘Because I have told them all now, and [it’s easier to talk] when you know you don’t need to 
try to conceal something.’ (Oster et al., 2013, p. 335).  The process of being open and honest 
about their cancer experience strengthened their existing relationships and helped form new 
friendships, leading to greater acceptance of their situation.    
However, changes in the body envelope had the capability of effecting relationships, 
via diminished self-esteem and confidence, resulting in social withdrawal and isolation as a 
way of attempting to manage these difficult feelings.  Moreover, a lack of social contact had 
the potential to lead to experiences of depression and anger, along with negative feelings 
directed towards themselves: 
I did not want to go out. I felt very depressed and angry with my altered appearance, 
because I was totally unprepared; it was painful for me to accept this. The reason I felt 
depressed was that I saw myself slobbering . . . everyday . . . and that has affected my 
self-esteem. (Hu et al., 2009, p. 329).  
EMOTIONAL EXPERIENCES OF CANCER TREATMENT                                                                                 1-22 
 
 Similarly, changes to the body that impeded acts of partner intimacy as a result of 
surgery were sources of concern and distress for both men and women.  Some men found that 
feeling sexually inadequate led to emotional changes ranging from angry to sad: ‘I have 
experienced that I have become so temperamental. My mood changes so quickly. I can lose 
my temper . . . inside myself . . . and then it can go the other way and I get sad’.  (Oster et al., 
2013, p. 335).  In comparison, some women were concerned about their ability to remain 
sexually attractive to their partners as a result of a mastectomy: ‘When I look at myself in the 
mirror, I just want to cry.  I feel it is not me.  Where is the good looking woman whom I 
knew?  How my spouse will even look at me now?’ (Joulaee et al., 2012, p. 3). 
 In contrast, women who undertook surgery to remove the invisible uterus, in essence 
castrating surgery, did not experience negative feelings about their bodies: ‘I am the same 
even if some parts of my body have been removed.’ (Ekman et al., 2004, p. 180).  
Furthermore, the emotional experience from undergoing a bone marrow transplant, after 
being diagnosed with haematological cancer, was notably different to that experienced by 
those whose treatment resulted in changes to the body envelope, suggesting that changes in 
body image had an emotional impact post-surgery. 
Reflections on the emotional journey having completed treatment 
 The completion of cancer treatment gave pause for reflection on the impact of having 
cancer.  Comparisons were commonly made between outlook of life and priorities pre and 
post cancer.  Some of the changes were profound and reflected feelings of being grateful for 
being alive and healthy, savouring the moment and viewing the world with a sense of awe.   
My world has absolutely changed. I could hardly feel how valuable my health was, 
but now I want to devour any single moment of my life. Everything is important, even 
simple natural events such as rain, sunshine . . . in everyday life can be a message to 
help me discover the meaning of life.  (Joulaee et al., 2012, p. 5). 
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Similarly, even when the cancer treatment journey had resulted in visible differences 
and stigma, acceptance and hope for the future were experienced:  ‘. . . I am only 40. So I tell 
myself just face the music... I never think it is a burden; it is a part of my life now.’  (Hu et 
al., 2009, p. 330). 
However, despite successful completion of curative cancer treatment, many difficult 
emotions related to cancer remained for many people.  Check-up protocols could be a source 
of uncertainty and reassurance for many, acting as a reminder of the potential of contracting 
cancer again, and providing confirmation that cancer had not returned.  Furthermore, fear of 
cancer returning led to hypervigilance, checking the body for any changes that may signal the 
presence of cancer: ‘It has almost become a routine now that when you have a shower you 
look at yourself and check that everything is ok.’ (Vaartio et al., 2003, p. 185). 
 Moreover, despite having successful curative treatment, for some people aspects of 
the treatment itself were a greater source of fear than that of contracting cancer again:  
I worry about developing secondary forms of cancer and having to go through 
treatment again. Cancer itself does not scare me – it is the treatment that scares me…I 
would really like to forget about the cancer. I get so upset always thinking about being 
monitored all my life… that the cancer doesn’t come back.  (Leal et al., 2015, p. 142). 
Therefore, cancer treatment of and in itself could elicit many distressing emotions 
above and beyond its contraction.  Primarily there is a sense that cancer continues to pose a 
threat and that regular medical monitoring could act as a reminder of this threat, potentially 
eliciting feelings initially evoked during cancer treatment. However, having undertaken and 
completed successful curative treatment, many participants found a new sense of self, 
demonstrating personal growth as a result of completing the journey.  
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Discussion 
 This review has highlighted some key emotional experiences related to undertaking 
and completing a curative cancer journey.  The emotional journey was analysed in four 
emotional sequential transition points: rapidly changing emotions at diagnosis; an action 
focused period with fewer and more stable emotions at the time of treatment; anger and 
sadness at what has been lost, post treatment; life after treatment signalled a period of 
emotional reconciliation and benefit finding.  The thematic synthesis method has allowed for 
many different types of cancer and a varied sample to be incorporated into the review from 
which common emotional experiences and concerns have been identified.  Due to the 
variation in the studies (country of origin and type of methodology) and sample 
characteristics (such as age, cancer stage, as well as gender and culture), the review findings 
can be considered theoretically generalizable (Yardley, 2000).  Furthermore, demonstration 
of how emotional experiences are related to coping strategies, are important considerations 
for health care services and organisations involved in cancer treatment and recovery. 
 Other thematic syntheses have revealed similar temporally structured themes that 
denote different pockets of experience split by life pre, during and post diagnosis and 
treatment for chronic conditions, for example, a thematic synthesis on experiences of 
dementia (Bunn, et al., 2012).   Furthermore, a thematic analysis on human 
immunodeficiency virus (HIV) (Heiland et al., 2008) split the analysis into five time periods 
from pre diagnosis through to the future with HIV, in order to illustrate how meaningful 
activities changed over time. 
 Being diagnosed with cancer, a potentially life threatening illness, associated with 
difficult and assumed maladaptive feelings, did not turn out to be a life shattering event.  In 
fact, similar to other long term conditions such as dementia (see Bunn et al., 2012 for a 
review), many studies reported participants adopting new insights and life perspectives as a 
EMOTIONAL EXPERIENCES OF CANCER TREATMENT                                                                                 1-25 
 
result of having cancer, despite initially experiencing difficult emotions related to cancer 
diagnosis and treatment.  
 Furthermore, participants illustrated how over time social comparisons were used in 
order to adapt.  This was particularly striking post cancer treatment when hopes of returning 
to their ‘old lives’ held during treatment had given way to the realisation that life, as a result 
of experiencing cancer, would be different, despite no longer having a cancer diagnosis.  This 
was particularly apparent when changes in the body envelope occurred as a result of cancer 
treatment.  More specifically, people with more visible difference as a result of treatment, 
could experience feelings of embarrassment and shame that often led to social avoidance, for 
fear of judgement.  In these circumstances, opportunities to self-regulate with others having 
undergone similar lived experience were particularly valued and beneficial.  Similar themes 
have been demonstrated in other areas, such as amputee experiences (see Murray & Forshaw, 
2013, for a metasynthesis) in which changes in identity occurred as a result of limb 
amputation and social comparisons were demonstrated as a useful mechanism for adopting 
and adapting to a new sense of self.    
Gender differences in emotional responses were detected.  As observed in studies of 
men with cancer in this review (Hu et al., 2009; Oster et al., 2013; Vaartio et al., 2003) men 
tended to talk about concrete actions as opposed to emotional experiences.  Men tended to 
turn to female spouses or family members for emotional support and expression, whereas 
women were more likely to be more emotionally expressive about both their own and their 
spouses’ experiences.  This phenomenon has been explained through socially constructed as 
well as cultural differences (Seymour-Smith & Wetherell, 2006).  Furthermore, as noted by 
Hu et al. (2009), men are less likely acknowledge the need for and accept more formal types 
of support, instead preferring the more informal support from other men who have shared 
similar experiences. This is an important consideration for cancer services offering support, 
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particularly when difficult feelings or embarrassment are being experienced as a result of 
cancer treatment. 
Furthermore, partners and family members were often mentioned, by both men and 
women, as important sources of emotional support throughout their cancer treatment. Given 
the importance of partners and family members, their inclusion in psychoeducation and 
interventions around support could be an important addition, particularly in reducing feelings 
of isolation, which are often involved in the cancer journey. 
Finally, having faced cancer treatment and the many emotional experiences expressed 
through the narratives of the participants involved, it is clear that distress, hope and 
expressions of personal growth are often intertwined, as opposed to discrete states.  
Therefore, this review supports studies that have demonstrated that the complex and evolving 
nature of felt emotions, where difficult emotions can co-exist with experiences of personal 
growth and contentment. 
However, it should be noted that each participant used and had available to them 
different strategies and resources in order to cope with their cancer journey.  Furthermore, 
despite some participants having had the same cancer type and undergoing similar treatment 
protocols, how each participant felt and reacted to their situation varied.   Some mentioned 
having supportive spouses, family and friendships and using these relationships in order to 
navigate the many demands that undergoing cancer treatment brought.  Other participants 
spoke about difficulties in their relationships and coping with responsibilities and stressors.  
Differences in both resources available to an individual and the amount of stressful factors 
they were attempting to balance is likely to mean that any interventions would need to be 
both flexible and timely enough to take into account each individual’s set of circumstances.  
This has implications for cancer services as being able to access them at the right time and 
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receive a unique level of support, tailored to an individual will be important for delivering 
effective interventions.  
In terms of limitations, the thematic synthesis relies on the language of the 
participants to illustrate their emotional experience.  However, social and cultural norms exist 
that influence how emotions are expressed, for example, in the UK there was a culture of 
‘being positive’ in cancer care. Although there is every reason to suspect that this culture was 
adopted more widely as one of its functions was negate fears of concerned friends and 
relatives (McCreaddie, Payne & Froggatt, 2010).  However, this review also relied on the 
interpretations of the researchers, who would have had an awareness of social and cultural 
norms and interpret participants’ quotes within this context.  Furthermore, cultural 
differences in cancer treatment were detected in the process of conducting this review which 
were not explored, such as access to the healthcare and type of health care provided.  
However, this could prove a valuable line of enquiry for future research. 
In conclusion, this review has provided a thematic synthesis of 12 papers in order to 
identify and understand the important emotional experiences of people undergoing cancer 
treatment.  This review used key stages of the cancer journey in which emotional experiences 
intensify and highlights how these emotions interplay with thoughts and actions designed to 
manage and cope with changing life and identity resulting from a diagnosis of cancer and its 
subsequent treatment.  The synthesis demonstrates and consequently supports the view that 
emotions throughout the cancer journey are complex and numerous.  Furthermore, these 
emotional experiences often lead to the natural adaption and adoption of a new perspectives 
and identities that differ from those held before cancer.  However, it should be noted that 
there are points in the cancer journey that can be experienced as particularly difficult, which 
may prove more so for individuals who are less resourced to cope with these experiences, due 
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to social isolation or cancer type and treatment, who may require more support and 
intervention. 
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Figure 1. Flow diagram for inclusion of papers in the thematic synthesis. 
 
 
 
 
Total papers yielded by title 
and abstract search: 12,496 
(Pub Med = 5,586; Cinahl = 
118; PsycInfo = 1,540; Web 
of Science = 5,252).   
Total after de-duplication: 
7,093. 
Title and abstract review 
excluded 6,094 papers: 
 Duplicates (n = 544) 
 Title screening (n = 
4,400) 
 Abstract screening (n 
= 1,150) 
Full text copies of 
remaining papers were 
obtained (n = 99) 
87 papers excluded due 
to: 
 Not meeting inclusion 
criteria (n = 16) 
 Not meeting exclusion 
criteria (n = 70) 
 Unable to obtain (n = 
1) 
Papers included in the 
meta-synthesis (n = 12) 
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Table I. Summary information of the papers selected for the meta-synthesis. 
Study 
No. 
Authors Research 
question/aim 
Methodology Participants 
1 Ekman 
et al., 
2004 
Enrich the 
understanding of 
the patient’s 
perspective of 
being diagnosed 
and treated for 
ovarian cancer. 
Hermeneutical 
approach 
 
Interviews 
conducted on 3 
occasions 
(diagnosed, during 
treatment, 
completion of 
treatment) (n-23). 
Sample size = n - 10.  Aged: 
21 -56.  Sex: Female. 
2 France 
et al., 
2000 
Describe 
psychological 
and social 
consequences of 
breast cancer in 
men. 
Phenomenological 
approach 
 
Unstructured 
interviews 
conducted in 
participants home 
with spouse invited 
to participate if 
present. 
Sample size = n - 6.  Aged: 
known.  Sex: Male.   
Completed curative 
treatment. 
3 Hu et 
al., 
2009 
Provide in-depth 
depictions of the 
experience or 
oral cancer in 
Taiwanese men. 
Thematic analysis 
 
Semi- structured 
interviews 
conducted face to 
face in hospital room 
or at home. 
Sample size = n - 6.  Aged: 
40 -57.  Sex: Men.  
Completed curative treatment 
for non-terminal cancer. 
4 Joulaee, 
et al., 
2012 
Explore the 
meaning of 
living with 
cancer for 
Iranian women. 
Phenomenological 
approach 
 
Semi- structured 
interviews 
conducted in a 
private breast cancer 
clinic. 
Sample size = n - 13.  Aged: 
34 -67.  Sex: Women.  
Completed curative 
treatment, including 
mastectomy/lumpectomy and 
chemotherapy/ radiotherapy. 
5 Leal et 
al., 
2015 
Explore 
patients’ 
experiences of 
cancer over 
time. 
 
(Part of an RCT 
for a yoga 
intervention). 
Content analysis 
using a framework 
approach 
 
Semi-structured 
written narratives, 
recorded at one 
week and three 
months post a yoga 
intervention. 
Sample size = n - 28.  Aged: 
34 -67.  Sex: 18 Women, 10 
men.  Diagnosed with 
lymphoma who are receiving 
curative treatment or had 
received treatment in the last 
12 months. 
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Table I. (Continued) 
Study 
No. 
Authors Research question/aim Methodology Participants 
6 Oster et al., 
2013 
Describe experiences 
of men living with 
prostate cancer. 
Content analysis 
 
Focus group with 
men undergoing a 
course of curative 
radiotherapy 
treatment. 
Sample size = n 
- 9.  Aged: 26 -
58.  Sex: men. 
 
One of two 
groups (split n -
6 & n - 3) that 
met six or seven 
times. 
7 Papadopoulou, 
et al., 2016 
Explore patients’ main 
pathways toward 
making sense of have 
been diagnosed with 
acute leukaemia within 
the first year after 
diagnosis or relapse. 
Interpretative 
phenomenological 
analysis approach 
 
Two Face to face 
semi- structured 
interviews at two to 
four week intervals. 
Sample size = n 
- 10.  Aged: 18 
– over 61.  Sex: 
Women = n - 3, 
Men = n - 7. 
 
20 interviews in 
total 
 
8 Taleghani, et 
al., 2008 
To investigate the 
experience from the 
patients perspective 
and how they interact 
with others and 
interpret their 
experiences in 
adjusting to the 
disease. 
Grounded theory  
 
2 Hospitals in 
Tehran (a university 
hospital and a 
private hospital). 
Sample size = n 
- 20 during 
treatment and 
15 after 
treatment.  
Aged: 31 -56.  
Sex: Women =  
45 interviews in 
total. 
9 Vaartio, et al., 
2003 
Find out what male 
cancer patients 
regarded as most 
problematic during 
their illness trajectory, 
what kind of internal 
and external resources 
they use and how they 
experienced social 
support during the 
illness trajectory. 
Content analysis 
 
Semi- structured 
interviews 
conducted in a 
private breast cancer 
clinic. 
Sample size = n 
- 8.  Aged: 42 -
64.  Sex: men. 
 
Diagnosed with 
melanoma, 
stomach cancer, 
lung cancer, 
Hodgkin’s 
disease, 
testicular 
cancer, prostate 
cancer and 
bladder cancer.   
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Table 1. (Continued) 
 
Study 
No. 
Authors Research question/aim Methodology Participants 
10 White-Means, 
et al., 2015 
Explores experiences 
during and post 
treatment that 
contributed to their 
beating the high odds 
of mortality. 
Thematic analysis 
 
Focus group using 
semi-structured 
interview. 
Sample size = n 
- 10.  Aged: 38 -
62.  Sex: 
women. 
 
Diagnosed with 
breast cancer. 
11 Winterbottom 
& Harcourt, 
2004 
Experience of living 
through a skin cancer 
diagnosis. 
 
(Only malignant 
melanoma sample 
used) 
Thematic content 
analysis 
 
1:1 semi-structured 
interviews. 
Sample size = n 
- 5.    
Aged: 24 -90.  
Sex: 3 women 
& 2 men. 
 
Diagnosed with 
malignant 
melanoma skin 
cancer. 
12 Xuereb & 
Dunlop, 2003 
Experience of 
haematological cancer 
through leukaemia or 
lymphoma and a bone 
marrow transplant. 
Phenomenological 
analysis 
 
Face to face semi-
structured 
interviews.  
 
Haematology units 
of three major 
hospitals in Sydney 
Sample size = n 
- 10.   Aged: 27 
- 54.  Sex: 6 
women & 4 
men. 
. 
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Table II. Critical appraisal of study quality using the CASP qualitative appraisal tool. 
* Items in columns 2-9 here correspond in the same order to items 3-10 on the CASP appraisal tool. 
 
Study 
 
Authors 
*Research 
design 
 
Sampling 
Data 
collection 
 
Reflexivity 
Ethical 
issues 
Data 
analysis 
 
Findings 
Value of 
research 
Total 
score 
1 Ekman et al., 2004 3 3 2 3 2 3 3 2 21 
2 France et al., 2000 3 3 3 1 1 2 3 2 18 
3 Hu et al., 2009 2 2 3 1 2 2 3 2 17 
4 Joulaee et al, 2012 2 2 2 1 2 2 3 2 16 
5 Leal et al., 2015 3 2 3 1 1 3 3 3 19 
6 Oster et al., 2013 2 2 3 1 2 2 3 2 17 
7 Papadopoulou et al., 
2016 
3 3 3 3 3 3 3 3 24 
8 Taleghani et al., 2008 3 3 3 1 2 2 3 2 19 
9 Vaartio, et al., 2003 2 2 2 1 2 2 3 2 16 
10 White-Means et al, 
2015 
2 3 3 1 2 3 3 3 20 
11 Winterbottom & 
Harcourt, 2004 
2 3 3 1 3 2 2 2 18 
12 Xuereb & Dunlop, 
2003 
3 3 3 1 2 2 2 3 19 
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Table III. Study contribution to reviewers’ themes. 
Study Authors Reviewers’ themes contributed to 
 1 Ekman et al., 2004 Being diagnosed and facing treatment 
Getting rid of cancer 
Changed body and stigma 
 2 France et al., 2000 Being diagnosed and facing treatment 
Getting rid of cancer 
Changed body and stigma 
 3 Hu et al., 2009 Being diagnosed and facing treatment 
Changed body and stigma 
Reflections on the emotional journey having 
completed treatment 
Reflections on the emotional journey having 
completed treatment 
 4 Joulaee, et al., 2012 Being diagnosed and facing treatment 
Changed body and stigma 
Reflections on the emotional journey having 
completed treatment 
 5 Leal et al., 2015 Being diagnosed and facing treatment 
Getting rid of cancer 
Reflections on the emotional journey having 
completed treatment 
 6 Oster et al., 2013 Being diagnosed and facing treatment 
Getting rid of cancer 
Changed body and stigma 
Reflections on the emotional journey having 
completed treatment 
 7 Papadopoulou, et al., 2016 Being diagnosed and facing treatment 
Getting rid of cancer 
Reflections on the emotional journey having 
completed treatment 
 8 Taleghani, et al., 2008 Being diagnosed and facing treatment 
Getting rid of cancer 
Changed body and stigma 
Reflections on the emotional journey having 
completed treatment 
 9 Vaartio, et al., 2003 Being diagnosed and facing treatment 
Getting rid of cancer 
Changed body and stigma 
Reflections on the emotional journey having 
completed treatment 
10 White-Means, et al., 2015 Being diagnosed and facing treatment 
Getting rid of cancer 
Changed body and stigma 
Reflections on the emotional journey having 
completed treatment 
11 Winterbottom & Harcourt, 
2004 
Being diagnosed and facing treatment 
Getting rid of cancer 
12 Xuereb & Dunlop, 2003 Being diagnosed and facing treatment 
Getting rid of cancer 
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Appendices 
Appendix A 
Exact terms input for each database search 
PUB MED   
 (((((cancer patient*[Title/Abstract]) OR (patient*[Title/Abstract... (5586) 
(((((cancer patient*[Title/Abstract]) OR (patient*[Title/Abstract] OR client*[Title/Abstract] 
OR individual*[Title/Abstract]))) AND ((‘Neoplasms’[Mesh]) OR 
cancer*[Title/Abstract])) AND (emotion* OR experience* OR perception*)) AND 
((‘interviews as topic’[Mesh:noexp] OR ‘focus groups’[Mesh:noexp] OR 
narration[Mesh:noexp] OR qualitative research[Mesh:noexp] OR (((‘semi-
structured’[TIAB] OR semistructured[TIAB] OR unstructured[TIAB] OR 
structured[TIAB] OR informal[TIAB] OR ‘in-depth’[TIAB] OR indepth[TIAB] OR 
‘face-to-face’[TIAB] OR guide[TIAB] OR guides[TIAB]) AND (interview*[TIAB] 
OR discussion*[TIAB] OR questionnaire*[TIAB])) OR (‘focus group’[TIAB] OR 
‘focus groups’[TIAB] OR qualitative[TIAB] OR ethnograph*[TIAB] OR 
fieldwork[TIAB] OR ‘field work’[TIAB] OR ‘key informant’[TIAB])))) 
   
CINAHL  
S1 AB neoplasms or oncology or cancer Search modes - Find all my search terms 
S4 emotion* OR experience* OR perception* Search modes - Find all my search terms 
S6 S2 OR S5 
S5 - AB individual* OR client* OR patient* 
S2 – AB ‘cancer patients’ 
Limiters - Exclude MEDLINE records; Human; Clinical Queries: Qualitative - High 
Specificity; Age Groups: All Adult 
 
PsychInfo   
S9 
S5 AND S6 AND S7   
Limiters - Publication Type: Peer Reviewed Journal; English; Age Groups: Adulthood (18 yrs 
& older); Population Group: Human; Methodology: QUALITATIVE STUDY; 
Exclude Dissertations 
Search modes - Find all my search terms 
View Results (1,540) View Details Edit 
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Appendix A contd. 
 
S8 
S5 AND S6 AND S7   
Search modes - Find all my search terms 
View Results (10,273) View Details Edit 
 S7 
S3 OR S4   
Search modes - Find all my search terms 
View Results (1,121,860) View Details Edit 
 S6  
S1 OR S2   
Search modes - Find all my search terms 
View Results (55,776) View Details Edit 
 S5  
AB emotion* OR perception* OR experience*   
Search modes - Find all my search terms 
View Results (825,019) View Details Edit 
Appendix A contd. 
 S4  
AB patient* OR client* OR individual*   
Search modes - Find all my search terms 
View Results (1,121,860) View Details Edit 
 S3  
AB cancer patients   
Search modes - Find all my search terms 
View Results (24,247) View Details Edit 
 S2  
AB cancer   
Search modes - Find all my search terms 
View Results (47,474) View Details Edit 
 S1  
DE ‘Neoplasms’ OR DE ‘Benign Neoplasms’ OR DE ‘Breast Neoplasms’ OR DE 
‘Endocrine Neoplasms’ OR DE ‘Leukemias’ OR DE ‘Melanoma’ OR DE 
‘Metastasis’ OR DE ‘Nervous System Neoplasms’ OR DE ‘Terminal Cancer’   
 
Limiters - Publication Type: Peer Reviewed Journal; English; Age Groups: Adulthood (18 yrs 
& older); Population Group: Human; Methodology: QUALITATIVE STUDY; 
Exclude Dissertations 
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Appendix A contd. 
WEBOfScience  
# 9 5,252  #8 AND #5 AND #4 AND #3 
Indexes=SCI-EXPANDED, SSCI Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 8 381,438  #7 AND #6 
Indexes=SCI-EXPANDED, SSCI Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 7 1,439,812  TOPIC: (interview OR discussion OR questionnaire* OR 
focus groups* OR qualitative OR ethnograph* OR 
fieldwork OR field work OR key informant) 
Indexes=SCI-EXPANDED, SSCI Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 6 4,444,725  TOPIC: (interviews as topic OR focus groups OR narration 
OR qualitative research OR semi-structured OR 
semistructured OR unstructured OR structured OR 
informal OR in-depth OR indepth OR face-to-face OR 
guide OR guides) 
Indexes=SCI-EXPANDED, SSCI Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 5 1,897,676  TOPIC: (cancer* OR neoplasm*) 
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, 
ESCI Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 4 2,096,253  TOPIC: (experience* OR perception* OR perspective*) 
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, 
ESCI Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 3 4,546,508  #2 OR #1 
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, 
ESCI Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
 
# 2 4,546,508  TOPIC: (patients* OR clients* OR individuals*) 
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, 
ESCI Timespan=All years 
Edit  Select to 
combine 
sets.  
Select to 
delete this 
set.  
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Appendix A contd. 
# 1 157,090  TOPIC: (‘cancer patients’) 
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, ESCI 
Timespan=All years 
Edit  Select to combine 
sets. 
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Appendix B  
Example page of a data extraction table  
Paper Research question/aim Methodology Participants 
Ekman et al. 
(2004) 
Enrich the understanding 
of the patient’s 
perspective of being 
diagnosed and treated for 
ovarian cancer. 
Hermeneutical Approach 
 
Interviews conducted on 3 
occasions (diagnosed, during 
treatment, completion of 
treatment) (n-23). 
Sample size = n-10.  
Aged: 21 -56.  Sex: 
Female. 
Results  
Reactions to Diagnosis of cancer:   2 main types: little surprise or difficultly in grasping the fact.  The 
difference in reaction seemed to be connected with perceptions of cancer (i.e. causes death or a 
treatable tumour).  So it was not a big surprise.  In some strange way I knew what it was.  But the thing 
that astonished me was that I never felt tired or depressed.  Connected bodily signs to cancer ‘hard belly’ 
or urinary incontinence.  Feeling of a ‘spider in the body’. 
Versus those whom associated cancer with death or had experience with others who had died from 
cancer.  At the time felt ‘strong’ or ‘should make it’ The future is not accessible and I have no plans 
anymore. 
 
Described the mixed feelings that changed rapidly fear, strength, willingness to fight, astonishment, 
sadness, disappointment, shock, hope, worry, chaos and emptiness.  Everything was chaotic, and I didn’t 
have one clear thought in my head’. 
 
Patient’s Thoughts and Feelings During Chemotherapy:  Cancer became real and close.  Bodily signs 
such as alopecia developed.  ‘Fear’ of cancer developing in other part of the body but strong feelings of 
‘hope’ that they would be cured.   Treatment connected to feelings of hope ‘It must be something very 
strong in the medicines in that you feel so sick, but it will surely take away the cancer cells.’ 
Cancer is something ‘evil’ that should be removed from the body. 
 
Taking blood samples mentally difficult as it was a reminder of having a disease. 
 
Treatment even if good lead to problems (nausea, vomiting, fatigue, sweating, stress, loss of hair, 
isolation, stomach pain, heartburn, and anxiety). 
 
Feeling of have a ‘big gash’ after Chemo that should be healed – confirmation that treatment was 
effective. 
 
Feeling the Same Despite Castrating Surgery:  Despite removal of organs women did not feel differently 
about their bodies.  ‘I feel exactly the same.’  ‘ I am the same even if some parts of my body have been 
removed.’ 
 
Acceptance of Chemotherapy:  ‘The chemotherapy is a good poison that I believe in’.  The chemo was 
referred to in terms of something that would ‘cleanse’ the body of toxins. 
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Appendix C 
Example of a grouped concept  
3 4 5 7 8 9 10 
Hu et al 2009 
Joulaee at 
al 2012 
Leal et al 
2015 
Papadopoulou et 
al. 2016 
Taleghani 
et al. 2008 
Vaartio et 
al. (2003) 
White-
Means et 
al. (2016) 
Oral Cancer 
Breast 
Cancer Lymphoma Leukemia   
Breast 
Cancer 
Mixed 
Cancer 
(males) 
Breast 
Cancer 
Adapting to 
difference: 
Participants 
used a variety 
of strategies to 
adjust to their 
new appearance 
and the reality 
of living with 
cancer.  These 
included trying 
to maintain a 
positive 
attitude; 
developing self-
reliance; 
accepting their 
appearance; 
modifying their 
lifestyle; setting 
new life goals; 
and seeking 
knowledge 
about healthy 
living. Three 
have become 
cancer 
volunteers at the 
hospital where 
they were 
treated. 
Positive 
aspects: 
This was 
shown 
with 
explaining 
how a new 
look at the 
life could 
provide 
the women 
with breast 
cancer a 
wider 
angle of 
the human 
life. 
Experience of 
paradox: 
coexistence—
contradictory 
and surreal 
Transformation 
and Growth: 
Assimilating 
Leukemia:  The 
assimilation of 
leukemia starts 
within the 
transformation 
process and 
develops toward 
growth via the 
realization of 
mortality and the 
reprioritization of 
personal values.  
Leukemia, like 
any life-
threatening 
illness, shakes 
two common 
assumptions: 
those of 
immortality and 
invincibility.  
Described how 
he felt as 
‘unnerving’ 
choosing not to 
think about 
death.   Another 
participant 
explained that 
‘brushed with 
death’ have made 
her reprioritise 
was important in 
her life. 
Living with 
the Disease 
with 
Tolerance 
After all the 
treatments 
the fear that 
cancer 
might 
return kept 
them from 
future 
adjustment. 
As soon as 
they had 
any pain or 
discomfort 
they 
suspected a 
relapse or 
metasasis:  
‘It has 
almost 
become a 
routine 
now that 
when you 
have a 
shower you 
look at 
yourself 
and check 
that 
everything 
is ok.’ 
Every 
survivor 
agreed 
that their 
lives had 
changed 
forever, 
due to 
breast 
cancer. 
They now 
appreciate 
life a 
whole lot 
more. 
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Abstract 
Aim: To illustrate the self-directed difficult emotional narratives of people who had been 
treated for cancer.  
Method: Six adults, treated for different cancer types, were recruited from different cancer 
charities in the north-west of England.  A narrative approach was used to extract acts of self-
directed difficult emotions from across the stories.   
Findings: Four themes or acts that contained difficult emotions directed at the self emerged 
and included demonstrations of how and when disgust, guilt, shame and fear were 
experienced and as the narratives unfolded, how and when these emotional experience 
changed the self. 
Discussion:  The findings are partly consistent with previous research.  However, there are 
indictors that the self-directed disgust schema may be initiated as a result of physical changes 
associated with cancer treatment. 
 
Keywords:  Cancer, Emotions, Disgust, Narrative-Analysis 
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Cancer, as with other long-term health conditions, can impact both an individual’s 
mental health and how these individuals decide on and respond to treatment (e.g., DiMatteo, 
Lepper, & Croghan, 2000), adhere to treatment protocols (e.g., Reynolds, Bissett, Porter, & 
Consedine, 2016), and their duration of survival (e.g., Falagas et al., 2007).  In particular, 
anxiety and depression have been argued to be important psychological experiences among 
people who have a cancer diagnosis and are undergoing treatment (Hinz et al., 2010).  
However, having a diagnosis of cancer and subsequent treatment can involve 
experiencing a number of difficult emotions beyond the mental health problems of anxiety 
and depression, such as embarrassment, guilt and shame.  Although difficult emotions cannot 
always be assumed to be maladaptive, emotional experience can influence psychological 
health and affect behaviour which can then have implications for interaction and engagement 
with treatment processes throughout the cancer treatment journey.  For example, 
embarrassment and fear have been associated with delays in seeking medical care in cancer 
(e.g. Smith, Pope, & Botha, 2005).  Feelings of self-blame, guilt and shame have been 
demonstrated in breast (e.g. Glinder & Compas, 1999), lung (e.g. Chapple, Ziebland, & 
McPherson, 2004; Coughlan, 2004; Gulyn & Youssef, 2010) and colorectal cancer (e.g. 
Phelan et al., 2013), which can lead to social avoidance and affect intimate relationships. 
As well as shame, blame and guilt, more recently researchers have begun to consider 
the role of other emotions directed towards the self, such as self-disgust.  Self-disgust as a 
psychological concept is relatively new, although features unique to disgust can be used to 
distinguish self-disgust from other closely-related affective phenomena (i.e., shame, self-
hatred) in the general population.  Theoretically, self-disgust can be viewed as an emotional 
schema by which disgust is directed towards the self and, if enduring, can have negative 
consequences for a range of mental health and behavioural outcomes (Powell, Simpson, & 
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Overton, 2014a).  Schemas can be defined as cognitive frameworks that organise and 
interpret pieces of information and the relationships among them (DiMaggio, 1997).   
Similarly, emotional schemas are patterns of associations between perception, emotion, 
appraisals and cognition (Izzard, 2007) 
Much of the research on self-disgust to date is concentrated in mental health.  For 
example, self-disgust has been shown to function as an antecedent to the depressive 
experience and play a role in depression (Overton, Markland, Taggart, Bagshaw, & Simpson, 
2008).  However, certainly from a theoretical perspective, self-disgust may also persist in the 
absence of depressive experience (Powell et al., 2014a), and there is some support for this in 
a recent longitudinal study (Powell, Simpson & Overton, 2013). The same research also 
found that disgust towards physical aspects of the self may be a more important predictor of 
depressive experience over time than disgust towards behavioural aspects of the self (Powell 
et al., 2013).  It is likely that physical aspects of oneself that initiate self-disgust may also be 
especially important in physical health conditions such as cancer (Reynolds, McCambridge, 
& Consedine, 2015).  Furthermore, physical symptoms of ill health, as well as the effects of 
treatment, have the potential to initiate the self-disgust schema; therefore, in long-term 
physical health conditions these self-disgust elicitors can become commonplace and 
unavoidable (Reynolds et al., 2015).   
Due to the infancy of the concept of self-disgust, few studies have explored the role of 
disgust directed at oneself in people with long-term physical health conditions.  Recent 
studies using quantitative methodology have found that self-disgust is a mediator of 
psychological distress in adults with cancer (Azlan, Overton, Simpson, & Powell, 2016; 
Powell, Azlan, Simpson, & Overton, 2016).  The former study found that disgust sensitivity 
was more likely to predict depressive symptoms in cancer populations than matched controls 
(Azlan et al., 2016).  The latter study found that experiencing physical side-effects of cancer 
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treatments, such as nausea and bowel and bladder problems, considered to be elicitors of core 
disgust responses, were indicative of increased psychological distress.  Furthermore, the 
effect of core disgust side-effects on self-disgust were also moderated by one’s underlying 
disgust propensity.  In addition, self-directed disgust mediated the impact of core disgust 
side-effects on psychological adjustment to cancer treatment (Powell et al., 2016), 
highlighting the relevance of self-disgust in relation to the cancer journey. 
Additional indicators suggest that disgust is of particular importance in cancer 
treatment.  For example, a secondary analysis of a randomised control trial of 68 cancer 
patients assigned to a mindfulness or relaxation intervention investigated the impact of 
emotions on different types of avoidance such as cognitive, social, and treatment avoidance in 
people undergoing chemotherapy.  Compared with other difficult emotions (i.e., 
embarrassment and distress), disgust propensity was the most consistent predictor of 
cognitive, social, and emotional avoidance (Reynolds et al., 2016).  This finding gives further 
weight to the importance of difficult emotions, particularly the role of disgust in cancer 
treatment.  
 However, the theoretical story of how self-directed emotions, including self-disgust, 
develop and change throughout the course of cancer treatment is as yet unexplored.  Due to 
the schematic appraisal driven by self-disgust, it is likely that the disgust-based rejection of 
others may also be anticipated, leading to social withdrawal in order to avoid the expected 
rejection from others.  Therefore, it is suspected that self-disgust may be an important 
mechanism underpinning the social withdrawal common in adaption to long-term physical 
health conditions, including cancer (Reynolds et al., 2015).  In contrast, although current 
theories of self-disgust highlight negative implications, such as avoidance, self-disgust as a 
potential protective mechanism is even less well understood in a physical health context.  
Moreover, given the original role of disgust in the protection from threats to health, physical 
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health maybe a context in which self-disgust may also be beneficial, for example, avoiding 
social contact during chemotherapy reduces the risk of infection.  Given the role of self-
disgust in avoidance and/or protection, its potential impact on interactions with treatment and 
psychological wellbeing and therefore recovery are important to consider. 
Other concepts, such as stigma, have been implicated in social withdrawal as a result 
of having a cancer diagnosis (Chapple et al., 2004; Else-Quest, LoConte, Schiller, & Hyde, 
2009; Lebel et al., 2013).  Stigma results from undesirable external societal labelling of 
individuals and has been theorised to occur in two forms ‘felt’ and ‘enacted’.  The felt form 
of stigma can be defined as an internalised sense of shame, as a result of an appraisal of 
oneself, from having a socially unacceptable condition and the anxiety of potential 
discrimination as a result.  When discrimination occurs, this is enacted stigma (Goffman, 
2009).  However, stigma has been conceptualised more widely to include public and self –
stigma that involves negatives beliefs, feelings and behaviours, for example awkwardness and 
avoidance of people with stigmatised illnesses (see Corrigan & Watson, 2002, for a review).  
A number of studies involving people with cancer (Else-Quest et al., 2009; Lebel et al., 2013) 
have found associations between perceived (felt) stigma and self-blame and poorer 
subsequent psychological adjustment.  Additionally, disgust sensitivity of partners, as well as 
self-directed disgust in people with cancer, have been shown to lead to poorer psychological 
wellbeing (Azlan, Overton, Simpson, & Powell, in press).  This suggests that psychological 
adjustment is affected by the difficult emotional experiences associated with these concepts.  
Furthermore, Lebel et al. (2013) found that stigma was reported more in people who had been 
visibly changed as a result of their cancer treatment.  
Consequently, the primary aim of this study was to investigate the experience of 
difficult emotions directed at the self, throughout the course of cancer treatment.  The 
evidence from personal narratives can highlight when these emotions are most prominent 
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within the cancer treatment journey and, equally importantly, when and how they become 
more dormant, which can elucidate more theoretical questions, beyond reflections at specific 
points.  Moreover, a greater understanding of the psychological trajectory of difficult 
emotions directed towards the self in people who have had cancer will provide guidance to 
health care professionals working with this population.   
The specific research question for this study is: what are the narratives of self-directed 
difficult emotions in individuals who have experienced treatment for cancer, and how do 
these change perceptions of the self? 
Method 
 Design 
The aim of the study was to explore how the self is changed over the cancer journey 
and which difficult self-conscious emotions are associated with this.  In order to achieve this 
aim a narrative analysis approach was adopted.  In particular, the role of self-disgust and 
difficult emotions in avoidance and the potential impact on interactions with treatment, 
psychological wellbeing and recovery are of interest. 
Procedure 
 The researcher liaised with a number of experts by experience from cancer 
organisations and the Lancaster University School of Health and Medicine Research Ethics 
Committee in order to ascertain acceptability of the study materials.  Ethical approval was 
sought and gained from the aforementioned committee, prior to recruitment taking place. 
 Cancer charities within the North West of England were contacted and informed about 
the study.  Charities willing to advertise the study were sent study advertisement materials 
along with the participant information sheet (see appendix D for participant information 
sheet).  Any other information they wished to review, such as ethical approval, before 
promoting the study, was sent via university email. The promotion of the study by consenting 
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organisations was done via electronic media channels such as social media, website, email 
and online forums, as well as more traditional routes such as newsletters, word of mouth and 
notice boards.  Potential participants contacted the researcher directly or their contact details 
were sent via the charity organisation (after potential participants gave their permission for 
this information to be made available).  The researcher contacted all potential participants and 
ensured that participants had received and read the participant information sheet and had had 
a chance to have questions answered before interview arrangements were made.  If agreeable 
with the participant, a time and place for an interview to take place was made. 
 All interviews took place either within the centre in which the support groups were 
held or within participants’ homes, dependent on the preference of the interviewee.  Prior to 
the interview taking place, all participants were informed that that they could stop the 
interview at any time.  
Given the nature of narrative analysis, in that it is interested in individuals’ personal 
perspectives of their own story and sense of self by allowing space for the narrative to evolve, 
the interview was mainly unstructured and began by asking the main question: an invitation 
for participants to talk about their experience of difficult self-conscious emotions throughout 
their cancer journey.  However, in order to maintain the focus of the research question, the 
researcher asked questions to clarify a point, or to expand on an area of interest, from a 
neutral position.   
The duration of the interviews was between 31 and 95 minutes (M = 68 minutes, SD 
= 24 minutes).  Participants were made aware that they were free to withdraw at any time up 
until the analysis and write up of the study without giving reason or experiencing negative 
consequences.   
As current research suggests that people who have cancer show high prevalence rates of 
psychological distress (e.g. Zabora, BrintzenhofeSzoc, Curbow, Hooker, & Piantadosi, 2001),  it was 
possible that sharing the story of their journey through cancer treatment had the potential to cause 
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distress.  Before the start of the interview, interviewees were asked about their preference of action, 
should they become upset.  This included having a break, rescheduling, or contacting a named 
individual for support.  In accordance with ethical approval, participants were given the option of 
choosing a pseudonym, having a pseudonym assigned by the researcher, or retaining their own name 
which can prevent ‘loss of ownership’ (Grinyer, 2002).  All participants used either their name or 
derivative of their name.  Consent to participate was gained via the completion and signing of a study 
consent form.  Participants were signposted to services, if appropriate, and contact details made 
available as part of the study debrief.  A summary of the findings was sent to consenting 
participants, once the study had been submitted for assessment. 
Participants 
All participants attended support groups run by regional cancer charities.  They 
identified as having experienced difficult emotions about themselves, such as guilt, shame 
and disgust, from the definition given in the study information (see appendix C for study 
advertisement), either during or after their cancer treatment experience and prior to being 
interviewed.  Participants interested in taking part in the study contacted the researcher to 
arrange an interview time and date. 
Participants were 18 years and above at the time of interview, although may have 
been younger at the time of treatment.  They could not have a ‘watch and wait’ tumour 
diagnosis or be in active treatment (i.e. radiotherapy/chemotherapy) when they were 
interviewed but could be on less invasive treatments (e.g., hormone therapy with tamoxifen).  
Participants needed to speak English, as it was preferred that the speaker and 
interviewer/researcher be fluent in the same language in order for robust interpretations to be 
made from the narratives (Temple & Young, 2004).  Information on participant demographics 
was collected from the participants at the beginning of the interview and included age, 
gender, ethnicity, primary cancer diagnosis, type and duration of cancer treatment, age of 
NARRATIVES OF DIFFICULT EMOTIONS                                                                                            2-10 
 
onset and time elapsed since active treatment.  Details of participants’ demographics are 
displayed in Table 1. 
[INSERT TABLE 1 HERE] 
Sample 
An open approach to the sampling was adopted.  Six participants (four women and 
two men) aged between 57 and 77 years took part in the study.  All participants categorised 
themselves as either White English or White British. The size of the sample reflected the 
idiographic approach taken, where the depth and richness of the analysis was privileged in 
order to gain theoretical generalisability (Morse, 2000).  The types of primary cancer 
diagnosis included cancer of the breast, voice box, cervix and prostate, as well as lymphoma.  
The types of cancer treatment included surgical removal of the cancer in all cases, followed 
by a course of adjuvant therapy (chemo or radio therapy) for five participants (Dave, Joan, 
Marianne, Jules, Hazel).  One participant had received two cancer diagnoses as well as a 
secondary cancer diagnosis (Joan).  The time elapsed since being in active treatment ranged 
from 10 months to 12 years.   
Analysis 
Narrative analysis was used to analyse the interview data.  This type of analysis places 
emphasis on the interplay between self and context.  The core element of this type of analysis 
is the uncovering of the self-construct, in particular how participants viewed themselves and 
how this view is shaped.  Furthermore, it is focused on the process of shaping of the self and 
the contributing factors involved (Weatherhead, 2011).  This was a useful approach for 
answering the research question, in that it allowed for in-depth exploration of the 
development of difficult emotions directed towards the self, throughout cancer treatment.  
All the interviews were undertaken and transcribed verbatim by the researcher (see 
appendix A for sample transcription).  The narratives were read and re-read for key 
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experiences that related to difficult emotions directed towards the self.  An inductive process 
followed in which these experiences were compared and contrasted across the narratives and 
from which four temporal themes or Acts emerged (see appendix B for grouped data by Act).  
In addition, narratives were reviewed for cases which contradicted Act descriptions.  The 
Acts, when considered appropriate, were modified to accommodate such divergence.   
The type of analytical framework utilised was informed by Riessman (2005) and 
Williams (1984).  These frameworks have a particular emphasis on ‘what’ is being said, 
within the content of narratives, in contrast to ‘how’ it is being said.  As such, the narrative 
framework adopted was informed epistemologically by a critical realist position, whereby 
language is seen as a route to truth and meaning.   
Qualitative approaches, including narrative analysis, assume that the researcher will to 
varying extents, influence the research findings.  In order to ensure quality Yardley’s (2000) 
framework was adopted.  In concordance with this framework the findings and interpretations 
were discussed with academic and field supervisors, in order that the most credible analysis 
be presented from the data.  Furthermore, the use of participants’ language to illustrate and 
support findings enhanced the integrity of the analysis (Riessman, 2005: Yardley, 2000).  
Through reflection and supervision, the researcher’s own reflexive position and the potential 
influence of this on the analysis was limited.  Finally, transcripts were searched for 
contradictory instances and themes adjusted to accommodate any disconfirming cases. 
 
Findings 
Four Acts were revealed from the analysis, which were ordered temporally.  The Acts 
reflect common emotional experiences of the participants interviewed.  However, each 
narrative is not necessarily represented in every Act, rather the potency of the emotional 
experience by the majority.  When reading the quotations, […] indicates omitted words. 
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Act 1 – ‘I want it out’ 
The emotion of disgust entered the narratives at different time points.  However, there 
was much overlap between participants experience of disgust entering the narratives during 
the process of attempting to eliminate cancer from the body throughout treatment.  This act 
encapsulated the feeling of a need to cleanse the body of the contamination of cancer.   
Hazel’s narrative highlighted the priority given to ridding the body of this 
contaminant.  Other treatment options that may have meant prolonging cancers occupation 
within the body were discounted, despite the consequences of its immediate removal, being 
the loss of her voice: ‘I wanted it out. Get it out, out of the way.  I had no alternative’. The 
primary behavioural tendency associated with disgust is rejection (Rozin, Haidt, & 
McCauley, 2000). The above scene illustrated that the thought of cancer remaining in the 
body was so disgusting that it was immediately rejected: ‘I wanted it out’, eluded to the 
intensity of the desire to rid the self of this undesirable and contaminated property.  
Hazel’s narrative goes on to talk about her stay in hospital: 
I just wanted get home from the hospital, back to living in my own house.  I just 
wanted the hospital stay and all that goes with being in hospital, the…alien 
environment, as you might call it, to be over and done with.  I mean being in hospital 
a couple weeks... which wasn't that long really, is an environment in which you 
become quite institutionalised, I feel.  You rely on staff. I mean I had to learn how put 
a tube in there [points to throat] and clean it and make sure I didn't get blocked up 
with mucus.  Now that's fine they are showing you how to cope with life, but the 
quicker you do it, the quicker you get home.  But after two weeks in you feel rather 
cocooned, being looked after. 
Hazel’s use of the word ‘alien’ in reference to the hospital environment is interesting and 
suggests that this may act as a disgust elicitor and therefore, create a need to gain distance 
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from it.  The idea of disgust objects being ‘matter out of place’ has been proposed in relation 
to that which has an ‘alien’ characteristic about it (Douglas, 2003).  Furthermore, the hospital 
environment may have signified the disgusting features of the unhealthy self, for example, 
‘being blocked up with mucus’, creating a desire to protect the healthy self, by rejecting 
reminders of the sick self, including ‘being looked after’. 
 Other elicitors of disgust entered the narratives during active treatment.  Treatment 
itself could elicit a disgust response.  Marianne’s narrative highlighted how she felt about 
having radiotherapy: 
Very daunting at first, you know, because you just don't know what's going to 
happen... But after the first couple, it was alright really, I got on with it.  It made me 
feel tired.  Erm, I didn't like [pauses].  You have to sit there with your arms in a clamp 
and sit very still and I didn't like that, so.  I just had weird thoughts about it, thinking 
'Oh, is it doing me good or not'.  
Clearly, fear is an emotion within the narrative, however, Marianne’s appraisal of the 
radiotherapy treatment ‘is it doing me good or not’ suggested that radiotherapy could be a 
potential harmful contaminant to the body, signalling disgust.  Disgust has been consistently 
linked to the behavioural immune system, protecting against potential disease threats (see 
Oaten, Stevenson, & Case, 2009, for a review).  Marianne goes on to describe a ‘weepy rash’ 
resulting from the treatment, a physical presentation of harm, as if to confirm her appraisal of 
radiotherapy as something not to be trusted.  Also, the description of her bodily position, 
‘arms in clamp’, and being unable to move while the radiation beam penetrates her body 
gives the sense of an act of violation.  Marianne explained what she would think about during 
this process: 
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I was just thinking I was riding one of me horses or [laughs].  You know, just getting 
away from the thought of what was happening, not thinking about it.  And hearing the 
beams going and seeing the lights, I just tried to shut my mind off to it somehow. 
Marianne’s narrative illustrates how she used dissociation strategies in order to keep the 
experience separate, as an act of protection, preventing it from penetrating her sense of self.  
Cognitive reappraisal and avoidance have been found to be strategies adopted when 
attempting to regulate the emotion of disgust (e.g., Olatunji, Berg, & Zhao, 2017; Reynolds et 
al., 2016). 
Act 2 – ‘Something I’ve done’ 
 The majority of stories contained narratives of externally directed and self-directed 
blame and guilt in which the narrator began to reflect on why they had cancer.  Often these 
reflections involved previous life-style behaviours that conflicted with the dominant health 
narratives that suggest factors such as lack of good diet and exercise are associated with the 
risk of contracting some types of cancer.  Marianne’s narrative describes her need to find an 
internal cause for her diagnosis: 
I was looking up what’s the causes…There's all sorts of things, even drinking red 
wine, you know too much of it.  I do sort of drink too much, I know that, not so much 
since this actually, but...I was thinking 'It's probably my fault for drinking too much 
wine', or you know, something I've done, diet or...But I have a healthy diet.  
Later in Marianne’s narrative, having described seeking internal causes for her cancer, 
she reveals a sense of guilt for some of the support she received from her friends and family: 
‘I had to get my husband to drive me, because I'm no good at driving all that way and people 
had to take me to radiotherapy’, suggesting that Marianne perceived herself as a burden on 
other people. 
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Other narratives also suggested the pursuit of internal cause, leaving a sense of 
confusion at being diagnosed with cancer, particularly if lifestyle behaviours linked to cancer 
causality were absent: ‘Well you wonder why it happened?  How it happened?  And of course 
the 'Why me?'.  I've never smoked, I don't drink. I like a social drink.  Why does it happen?’  
(Hazel) 
 Within his narrative Dave introduces the discourse of a health professional, perceived 
to be more knowledgeable, experienced and powerful on the subject of factors that prevent 
cancer reoccurrence.  This narrative illustrates that despite the fact Dave does not specifically 
talk about guilt for contracting cancer, he alludes to internalised self-blame and guilt through 
his interest in preventative actions.  Dave also feels responsible for preventing cancer, 
through adherence to lifestyle directives in accordance with dominate health discourses that 
locate disease risk within the individual. 
 Joan’s narrative describes how internalised messages of individual responsibility for 
health are felt and expressed in anger towards others who violate dominant health narratives: 
Anger, with people who abuse themselves when they've got everything going for them 
and they don't realise.  Anger with people who drink, take drugs, and actually destroy 
their bodies, by choice.  When there are so many people out there who would do 
everything, just to have the chance of doing that.  Yes, I feel anger with them and I 
know it's a weakness, but yes.  I see young women in the street…vastly overweight, 
smoking, with kids eating everything they shouldn't … 
Joan’s narrative also eludes to disgust directed at others (socio-moral disgust).  Her use of the 
phrase ‘destroy their bodies’ and how this occurs ‘smoking’ and being ‘vastly overweight’ 
give the sense of self–contamination in others.  Consequently, Joan rejects the contaminated 
others, thereby protecting and maintaining the integrity of the self, particularly as smoking 
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and obesity are considered to have cancer causing properties.  Both smoking and obesity have 
been linked the emotion of disgust (e.g., Rozin & Singh, 1999; Vartanian, 2010). 
 
Act 3 – ‘That made me shudder’ 
 The narratives of participants who experienced changes to their body as a result of 
surgery all describe scenes in which they first experience these changes and how they felt.  A 
common feeling upon viewing themselves post-operatively was one of shock and feeling 
disgust.  Joan describes a scene in which she was having a bath in hospital after her operation. 
I didn't know what to expect…And this nurse had helped put me in this bath and of 
course I hadn't seen anything and there was a mirror behind me, and I turned in the 
mirror on the wall and I'd got this blanket stitch! Black blanket stitch! You know, 
where I'd had a breast it was just flat to my chest and a blanket stitch!  And I 
remember the shock of seeing it.  (Joan) 
Joan conveys feelings shock and disbelief.  The repetition of the phrase ‘blanket stitch’ 
provides insight into the exact focus for Joan within the scene and her attempts to marry the 
image she sees with the body with which she was familiar.  The description conveys a sense 
of loss, as Joan describes what is missing, ‘a breast’, then disgust at what was now occupying 
the area ‘a black blanket stitch’.  The type of stitch that Joan identified, a blanket stitch, is one 
that is associated with a use on a piece of material.  Joan also focuses on the colour of stitch 
‘black’, a colour that is in sharp contrast to the colour of her skin.  Both the type of stitch and 
the colour are out of place; in this sense, this part of the body is now seen as out of place by 
Joan.  Later in the narrative, Joan seeks a breast reconstruction in order to replace the alien 
part of the body (Douglas, 2002) with a more familiar and acceptable object, similar to her 
own breast, thereby reconciling this part of the body back into Joan’s ownership. 
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   Jules’ narrative expresses disgust as she describes more visceral responses on viewing 
her breast after surgery: ‘It just looks awful.  It makes me sick looking at it now sometimes.’  
The use of the word ‘sick’ highlighted that the subjective emotional experience of disgust 
goes beyond a cognitive one, instead the emotion is visceral and embodied.  The bodily 
sensation of nausea is typically associated with the rejection of an undesirable or harmful 
ingested object and the emotion of disgust (Stern, Koch, & Andrews, 2011). The word ‘sick’ 
provides a sense of how Jules feels about her breast – an undesirable and potentially toxic 
part of her body.   Nausea is a mechanism linked to the management of the indigestion of a 
potential toxin (Stern, Koch, & Andrews, 2011). 
Jules’ story conveys that even more than 10 years after her surgery, she can still 
experience the changed area of her body in the same way suggesting little change over time: 
‘It feels weird, even now it feels weird after all this time.’  This gives the sense that although 
the intensity of the emotion of disgust may have reduced, this part of the body still feels alien, 
causing distress, and remaining outside of Jules’ ownership.  The word ‘weird’ indicates 
‘matter out of place’ and therefore, an object of disgust (Douglas, 2002). 
 Jules describes how the changes to her body have affected other important characters 
in her life, in particular how it has changed intentions towards acts of intimacy:  ‘…this thing 
with my boob, like the way it looks and everything, you know it was a bit off putting... I 
didn't really want to go with anybody, for that reason, you know.’  The language conveys 
both how Jules feels a sense of disgust about this part of herself, how this feeling is 
elaborated on to include how she perceives others will think of her body.  Her use of the 
words ‘off putting’ suggests that others will view this part of her body as undesirable and 
therefore a barrier to sexual intimacy. There is also a sense that her changed breast has the 
power to contaminate, changing desirability to an untouchability that goes beyond her 
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changed breast and encompasses her sexual self.  As a result, Jules preferred to avoid others 
and the reminders of violated physical self. 
    Jules’ narrative goes on to describe how she has experienced an act of intimacy.  
‘…when they won't touch it...  But even after I've done the comedy bit, they're still iffy about 
touching it...’   Jules alludes to how she uses humour to manage both her feelings and the 
perceived feelings of her partner towards her changed breast.  However, Jules’ feelings of 
pain, shame and rejection are powerful and dominate the scene, as her attempts for this part of 
her body to be incorporated into acts of trust, connection and intimacy are thwarted.  The 
scene also conveys how Jules interprets the reactions of her partner as confirming that a part 
of her is disgusting, leading her to further internalise part of the self as disgusting.  
Internalising reactions of others, interpreted disgust and rejection, has been demonstrated to 
lead to self-directed disgust (Powell, Overton & Simpson, 2014b), and, therefore, alludes to a 
schematic perspective of self-directed disgust. 
 Marianne’s story also touches on concerns about the impact of her changed body on 
her relationship with her husband: ‘Cause I can be negative.  And he was fine.  And the scars 
and everything, he doesn't mind at all, you know, it's not put him off sex or anything.  Which 
some men I know it can do.’  There is a sense that initially Marianne feels shame about her 
changed body. The phrase, ‘which some men I know it can do’ certainly alludes to 
Marianne’s prevailing thought that it would bother men, and this probably extends to her 
husband, even though he is trying to show that it does not.  Marianne’s narrative illustrates 
her own negative appraisal of her changed body and how the reactions of her partner have 
been important in helping her cope with her changed body, preventing any initial feelings of 
shame or disgust from becoming deep-rooted.  As well as self-directed disgust in people with 
cancer, disgust sensitive of partners has also been linked to poorer psychological wellbeing 
(Azlan et al., in press). 
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 Hazel’s story reveals how she adapted to the sound of her voice post operatively.  
Initially, she used a valve and then a digital speech aid after her laryngectomy.  Hazel 
describes when she first heard someone speak with a valve, shortly before having a valve 
fitted herself: 
They came along to talk to me and I realised they can speak and it was enlightening to 
find that it wasn't all gloom and doom...  But they had a valve in and chatted away to 
me.  But it was the sound of it that made me shudder…It didn't sound natural.  It 
wasn't a natural voice…I think my mind was sort of in a bit a turmoil and I was 
getting used to the idea that I wouldn't sound like I did six months ago.  I would be 
different.  Would people accept me with a different sort of voice almost?  
Hazel’s descriptions and the use of the word ‘turmoil’ gave the sense of her battling to come 
to terms with the loss of her voice and the realisation that her life would be different after her 
laryngectomy.  Her thoughts then move on to question how relationships with people might 
be affected as a result of using a voice aid, particularly if Hazel’s first reaction was to 
‘shudder’, suggesting a visceral, aversive response to the voice that did not sound ‘natural’.  
The violation of naturalness indicates feelings of disgust in this part of the narrative. 
Hazel goes on to describe occasions when she is out in public: 
It's like going into a supermarket and speaking to my husband, you get people looking 
around, thinking ‘what's that strange noise?’  Now it doesn't bother me, and if children 
come up and I go, yes I have to speak like this.  It worried me more then.  I used to 
hide this [points to neck].  I used to wear neck scarfs…to hide the fact ... It's not only 
mentally, it's physical as well, the actual appearance.  My husband used to say, ‘well 
you don't notice it’.  But I say, ‘you may not, you're used to it, but people that you 
don't know DO [emphasis] notice’.  
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Within this description Hazel’s language conveys how she has adapted to going out in public, 
alluding to a sense of felt shame.  She notes that, despite reassurances from supportive family 
members, people unknown to her do notice her voice and neck, resulting from surgery.  The 
emphasis on the word ‘DO’ indicates that there is no doubt in Hazel’s mind that others will 
view her differently, separating her from typical social interactions and leaving her open to 
scrutiny.  The use of the word ‘strange’ also alludes to a sense of others finding Hazel 
disgusting, as a result of her voice sounding ‘mechanical’ (violation of naturalness).  Hazel 
pre-empts the negative evaluations and rejection, behaviours of enacted stigma, based on both 
her appearance and sound of her voice.  This narrative is conducive with the perspective of 
self-disgust as a schema, as Hazel’s appraisal of herself, past experiences and interpretations, 
lead her to conclude that others would find her disgusting. 
Act 4 - ‘It never really goes away’ 
 A common act within all the participant stories was that, having had cancer, their lives 
changed in many different ways as a result.  Many participants’ stories illustrated how the 
body was feared, due to the continued concern of cancer reoccurrence.  In this sense, the 
unpredictability of the future lead to a constant sense of fear and anxiety.  Furthermore, there 
were indicators that cancer had occupied the body and changed the self, leading to a sense 
that the body could not be trusted and that it had the potential to silently harbour a deadly 
toxin.   
I suppose it's just seeing it like, that was an enemy that you've knocked out, but don't 
turn your back on it because it might come up and stab you in the back again, you 
know.  So, you're aware of it.  (Dave) 
The use of the phrase ‘stab you in the back’ alludes to a sense of cancer taking you by 
surprise and that it is violent and potentially deadly.  The language in Dave’s narrative gives a 
sense that cancer is to be legitimately feared, as its intention is to kill you by your own body.  
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His body had betrayed him and is never to be trusted, in this sense there is a changed 
relationship with the self.  Dave’s narrative also gives the impression that he is alone with 
cancer and only he and not his body (as it has the potential to deceive, by silently harbouring 
cancer) can defend against it, again alluding to a sense of personal responsibility for 
containing the disease.  Dave’s narrative gives the sense of anxiety, leading to hyper-
vigilance for signs of cancer having returned. 
Anxiety generated by potential reoccurrence of cancer manifested itself in a number 
of ways.  Unexplained aches and pains, that before being diagnosed with cancer did not cause 
concern, prompted anxiety that they may signal the return of cancer:  ‘Oh yeah, every ache 
and pain I think 'Oh dear'.’ (Marianne)  This narrative also gives the sense that body can no 
longer be trusted, indicating that the anxiety is in part related to the body’s potential to be 
contaminated and alludes to emotion of fear directed towards the body itself.   
Hazel’s narrative explicitly indicates fear: ‘And then there's always the fear I think 
of… something more involved,... was it primary cancer, was it secondary cancer... you get a 
lot of very conflicting things in your head about it.’.  The narrative alludes to a sense of fear 
always being present.  Her use of the phrase ‘conflicting things in your head’ indicates a form 
of battle between cognitive appraisals associated with threat and reassurance as she attempts 
to manage fear. 
 Other participants described how cancer had impacted on their lives to the point that it 
had changed their interests.  All participants were part of cancer groups that met regularly and 
were involved in helping other people with a cancer diagnosis.  Jules and Dennis both 
describe how, since having cancer, they enjoyed attending groups, an action that they would 
not have done before.  Dennis illustrated how he has invested in helping other people with 
cancer at a wider systems level and at local support groups.  In order to guide medical 
services, Dennis described how he was involved in peer reviews of cancer services, using his 
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skills and abilities obtained pre-cancer diagnosed, as well as his experiences as a cancer 
patient.  These narratives illustrate actions related to keeping cancer close, in some respects, 
this may be seen as an act of guarding against cancer.  The body has the potential to harbour a 
toxin, therefore the body can be an object to be feared.  The acts that keep the cancer close to 
the self (social groups, etc.), can be perceived as strategies that seek to manage anxiety, not 
only by gaining a sense of control over the threat of cancer, but also reconciling the feared 
body back into the ownership of the self. 
Discussion 
 The narratives revealed a range of difficult emotions throughout the cancer treatment 
journey.  The effects of having a cancer diagnosis on the lives of the participants were varied 
and far reaching, affecting all areas of their lives.  The changes to participants’ sense of self 
post cancer compared to pre cancer dominated all of the narratives.  
As well as similarities across the narratives, differences across narratives were 
illustrated.  Later in the cancer journey emotional experiences differed, particularly those 
relating to changes of the body as a result of cancer treatment.  This was consistent with other 
studies involving visible difference (e.g. Rumsey, Clarke, White, Wyn-Williams, & Garlick, 
2004) and head and neck cancer (see Lang, Frances, Williams, Humphris, & Wells, 2013, for 
a meta-synthesis), in which physical changes resulted in long lasting difficulties particularly 
with social interactions including intimacy.  The emotional experience of participants 
converged around concerns of changes to bodies as a result of surgery and the impact of these 
changes on their lives going forward.  However, the narratives differed qualitatively in the 
type and impact of difficult emotions after surgery.  Within some narratives adaptation to and 
acceptance of the changed body was quickly reached.  However, in other narratives, stigma 
both ‘felt’ and ‘enacted’ continued for a substantial length of time, throughout the stories and 
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up to the time of interview.  Interestingly, these narratives contained visceral responses in 
reaction to their changed body image, signalling disgust directed at the self.   
From a theoretical perspective, the relationship between cognitions and emotions can 
be complex, taking on multi-level processing.  One model that has conceptualised multi-level 
processing is the SPAARS model (Power & Dalgleish, 1999), who purport that emotion is a 
‘holistic’ concept which includes an event, interpretation, appraisal, awareness and 
subsequent behaviour and has two routes of processing (associative and schematic).  Of 
particular interest is the schematic level of processing, which suggest that emotional schemas 
are shaped by learning, experience and culture, which form part of child development.  
However, it has been hypothesised that physical aspects of oneself can activate self-disgust 
(Reynolds, et al., 2015), and furthermore, that dysfunctional self-disgust schema can be 
created in adulthood (Powell, et al., 2014a).  Indeed some of the narratives illustrate this 
theoretical perspective, indicating that self-disgust schema could not only be activated but 
initiated by a physical change. 
However, some, but not all, physical change led to development or even demonstrated 
self-directed disgust.  This perhaps further strengthens the evidence for a schema perspective 
of disgust, as the presence of an event alone (i.e. physical change) did not automatically lead 
to the emotion of disgust.  It was more a process of interpretation and appraisal based on an 
interplay of sociocultural and individual characteristics and resources.  
 A number of theoretical explanations may provide insight for the lack of narrative 
illustration of disgust activated through chemotherapy, a treatment in which core disgust 
elicitors are plentiful.  Self-disgust may have been elicited by the side-effects of 
chemotherapy, particularly as descriptions of the side-effects were present within the 
narrative, however it may have been in an adaptive and constrained way, beneficial to the 
context, in that it acted to protect from threats of infection by limiting social contact while the 
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immune system was comprised. Indeed protective aspects of self-disgust have been suggested 
theoretically (Reynolds, et al., 2015) and found empirically, for example in wound care 
management (Gaind, Clarke, & Butler, 2011).    
Furthermore, if disgust responses are activated for a beneficial period of time (i.e. to 
reduce contact with potential contaminants), perhaps self-disgust as a schema within itself is 
not maladaptive, but rather the potential problem lies in the length of time that it remains 
activated.  If disgust responses continue beyond a period where they are useful for protection, 
its effects are likely to be more deleterious than beneficial, particularly in relation to social 
avoidance.  Certainly it may be fruitful for future research to investigate diverging disgust 
hypotheses, in order to test theoretical perspectives and inform clinical interventions. 
However, the narratives did allude to radiotherapy eliciting disgust responses.  These 
responses arose specifically from cognitive appraisal of the potential harm from the 
radiotherapy beam entering the body.  In terms of clinical implications resulting from this 
finding, it may be worth exploring cognitive reappraisal strategies for those undertaking 
radiotherapy, which may prove more beneficial than thought suppression which has been 
associated greater emotional distress (Olatunji, Berg & Zhao, 2017). 
  More notably, the external and internal attribution of blame, associated with feelings 
of guilt and shame, was featured within almost all the narratives with this study, suggesting 
that previous lifestyle behaviours may have caused their cancer.  Using the UK as an 
exemplar, although there are many other countries where similar examples can be found (see 
Raphel & Bryant, 2006, for a review), lifestyle factors dominate health promotion narratives.  
For example, UK cancer organisations suggest lifestyle behaviours such as smoking, activity, 
alcohol and diet all affect the risk of developing cancer, and go on to suggest that 4 out of 10 
cancers could be prevented as a result (Cancer Research UK, 2016).  However, who is 
responsible for the promotion of health and where the responsibility for determinates of 
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health lie are a source of much political debate, but broadly fall into two models: 
individualised, where the focus is on biological factors, and structural, in which the impact of 
society organisation and influences are considered key (Raphael & Bryant, 2006).  Although 
the policies of more recent UK governments have started to consider the impact of social 
disadvantage on health (e.g. Choosing health: Making healthy choices easier, Department of 
Health, 2004) many government funded media health campaigns still tend to focus on 
individual lifestyle behaviours, such as smoking and its links to the disease, in order to 
encourage behavioural change.  However, for those already with a cancer diagnosis, this may 
contribute to a sense of personal responsibility for contracting the disease, which in turn can 
encourage societal narratives that support this view. 
Encouragingly, all the narratives demonstrated a new sense of self develop after a 
period of disruption, worry and uncertainty.  Similar experiences have been illustrated in long 
term conditions generally (Charmaz, 1991).  Charmaz views social relations as a source of 
development and maintenance of the self in chronic illness.  As such, reactions of others can 
diminish or develop an individual’s sense of self.  In terms of the narratives featured in this 
study, being part of cancer support and self-management groups provided an opportunity to 
engage in meaningful social interactions, and was an important part of developing a new 
sense of self. 
However, support group membership and the extent of cancer severity, type of cancer 
and range of physical change did not dictate the nature and intensity of emotions and the 
subsequent responses to these emotions (i.e., avoidance).  Within the narratives there are 
indicators of how various strategies are adopted and resources available to individuals are 
used, particularly in relation to supportive relationships with spouses and friends, as well as 
drawing up on previous experiences to overcome demands and challenges of having cancer.  
Some narratives, however, highlighted the impact of more difficult relationships and 
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stressors, indicating that these could have an impact on emotional experience beyond cancer 
descriptors and support group membership.  In this regard, it is important for cancer services 
and health professionals to consider the unique perspectives and resources of individuals, as 
some people will need more individually tailored support than a standardised approach offers. 
However, others may find inventions unnecessary and even an unwelcomed interruption to 
their recovery, regardless of cancer type and severity. 
Moreover, difficult emotions, particularly those directed at the self may have 
implications for the development and maintenance of individuals’ sense of self throughout 
and post cancer treatment.  In this regard, health care professionals who have an 
understanding of the influence of self-directed emotions that lead to avoidance are better 
placed to recognise, support and manage individuals who are experiencing these emotions.   
In terms of the limitations, it is important to note that a small number of participants 
took part in this study.  However, due to the depth of the narratives, ways in which difficult 
emotions are experienced within the cancer treatment journey and how the self may be 
changed as a result are illustrated and therefore discussed in relation to theoretical 
perspectives.  Furthermore, all the participants were recruited via support groups related to 
cancer, therefore there may be differences in narratives between group attendees versus non 
attendees, especially as the stories of the participants in this study indicated that group 
membership was an important part of their cancer journey, particularly in gaining a social 
network and acceptance.  However, the illustrations highlighted within this study of how 
group membership supports and shapes sense of self is interesting, especially when 
considering clinical implications and interventions.  Nonetheless, it should be noted that 
support group membership might not be beneficial for all.  For example, a qualitative study of 
people with a Parkinson’s disease diagnosis, exploring group membership, demonstrated that 
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non-group members found the idea of group membership distressing, preferring to use other 
coping mechanisms (Charlton & Barrow, 2002).   
 In conclusion, analysis of these narratives demonstrate that difficult emotions directed 
at the self could manifest at different times and in different ways.  They could be enduring, 
affecting sense of self and daily living.  It is important to recognise and understand these 
emotions in order to create and shape individualised support and interventions for people 
struggling to reach a new sense of self.  In this regard, more qualitative research is needed in 
order to help researchers, health professionals and services to further understand the 
processes of difficult self-directed emotions.  
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Table I. Summary participant demographics. 
Name  Age Ethnicity  Primary 
cancer 
diagnosis 
Cancer 
treatment type 
Duration 
of 
treatment 
Age 
of 
onset 
Time lapse 
since active 
treatment 
Dave 77 White 
British 
Non-
Hodgkin’s 
Lymphoma 
Surgical 
Removal & 
Chemotherapy 
7 months 74 2 years 
Hazel 74 White 
British 
Vocal 
Chord 
Surgical 
Removal & 
Radiotherapy 
4 months 64 10 years 
Jules 68 White 
British 
Breast Lumpectomy 
& 
Radiotherapy 
6 months 57 10 years 
Dennis 68 White 
British 
Prostate Radical 
prostatectomy 
2 months 58 10 years 
Joan 74 White 
British 
Cervix Surgery 2 weeks 37 12 years 
Marianne 64 White 
British 
Breast Lumpectomy 
& 
Radiotherapy 
4 months 64 10 months 
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Appendices 
Appendix A 
Sample transcription 
 
Interviewer: Can you tell me how you felt about yourself throughout your cancer journey? 
Interviewee: Annoyed [laughs].  Annoyed because I didn't want it to happen.  Upset initially 
and then a bit sort of euphoric as it when on, you know.  Trying to put it to the back of my 
mind, I think. 
Interviewer:  Which bits were you more upset, at the beginning? 
Interviewee:  The beginning yeah and thinking, 'Oh it'll just spread', you know.  I had a 
strange feeling as well when I had the mammogram, I sort of knew, even though there wasn't 
a lump.  I got letter through the door to go to back and I said 'I knew this was going to 
happen'.  I just had it in my head somehow. 
Interviewer: So was it a standard screening mammogram? 
Interviewee:  Yeah just normal.  A 3 year one, yeah. 
Interviewer:  Did you feel anything had changed in your body? 
Interviewee:  No, no.  Cause it wasn't an actual lump, it was... they called it a mass, more than 
anything. 
Interviewer:  So what did you feel when you hear that, the idea of a mass. 
Interviewee:  Well I was horrified.  I didn't like it.  I just wanted to get the operation done.  So 
it was actually 3 weeks before I had it done, because I had to have a erm...What's it called as 
wire led... Wire lead into the breast, so the surgeon could see where the lump was, because it 
was more inside than outside.  So the radiologist had to do that, so he wasn't available for 3 
weeks.  So I had 3 weeks were I was quite upset, you know worrying about.   
Interviewer:  So you were upset at the idea of... 
Interviewee:  Having the cancer and has it spread, and... Because I don't...I've had a few 
friends that have had cancer and their not here now so.   
Interviewer: I was going to ask what your previous experience of cancer was. 
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Appendix B 
Example of a grouped concept (Something I’ve done) 
Dave Hazel Jules Dennis Joan Marianne 
Yeah, and they 
were only in 
their early 
60's.  My 
mother died 
first, she had 
breast cancer.  
Then my Dad 
died of bowel 
cancer, 18 
months later.  
So it's not a 
well liked 
disease in my 
family.  Well 
it's not a well 
liked disease 
in any family!  
(p8) 
:  Not 
really.  You 
take good 
health for 
granted, it's 
only when 
things start 
going 
wrong or 
went wrong 
that you 
realise we're 
all 
vulnerable 
one way or 
another.  
Because I 
mean I 
never 
smoked and 
I was told 
initially, it's 
a smokers’ 
cancer.  It's 
often 
associated 
with people 
who smoke 
a lot.  I 
don't 
smoke, I 
never have 
smoked, 
so... (p5) 
Well we 
actually went 
into that about, 
you know, 
whether it 
would be 
carried on 
because there 
was nothing in 
the family 
beforehand to 
suggest cancer 
was in the 
family and I 
think as far as I 
know 
everything was 
ok with that, 
you know. It 
was like a one 
off kind of 
thing.  They did 
say it was 
lifestyle.  I 
don't know 
what they say 
by lifestyle, 
what that 
means?   I had 
too much ice 
cream 
probably, you 
know (laughs). 
 
 And I had a 
lot of stress 
at work, so I 
put the 
stress... I also 
think the 
stress, plus 
the fact I was 
given HRT, 
and one of 
things the 
doctor did 
say 
afterwards, 
cause I said, 
'Could this 
have been...' 
I had it for 3 
months and I 
just bleed.  I 
just said, 
'could it have 
affected it', I 
said 'Could it 
affect it?' 
(p2) 
Oh I was 
looking all 
sorts up! As 
you do, yeah, 
yeah. [laughs] 
All different 
kinds of cancer 
and....Mine 
was called 
ductal cancer, 
which was in 
the milk ducts, 
and he asked 
me if I'd 
breastfed and I 
said 'Yeah, is 
that a good 
thing or a bad 
thing?'.  He 
said 'Oh I don't 
know really'.  
So you think 
should I have 
breastfed or...?  
He wasn't 
committing. 
(p6) 
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Appendix C 
Sample advertisement 
 
 
 
Have you experienced difficult emotions about yourself 
during your cancer treatment journey? 
 
As a result of the experience of being diagnosed and treated for 
cancer, some people can find that they experience difficult feelings 
about themselves - feelings such as guilt, shame or disgust. 
 
If you have experienced these feelings, are not having active 
treatment, and are over 18 years old, I would love to hear your story. 
 
For more information visit *insert link to PIS*.  Or please contact me 
on:- 
 
Selane Rigby    Tel:  xxxxxxxxxxxxx 
Email: s.rigby1@lancaster.ac.uk 
Trainee Clinical Psychologist 
Faculty of Health and Medicine  
(Division of Health Research)  
Lancaster University  
Lancaster  
LA1 4YG 
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Appendix D 
 
Participant information sheet 
 
 
 
Participant Information Sheet 
 
Understanding difficult emotions about yourself in the cancer treatment 
journey 
 
My name is Selane Rigby and I am conducting a study as a trainee clinical psychologist at 
Lancaster University, Lancaster, United Kingdom.  I am interested in the feelings people 
have about themselves during cancer treatment.  I am looking for volunteers to take part in 
a study which will involve talking to me on a one to one basis about these feelings.  
However, before making any decisions about whether you might want to be interviewed, I 
would like to ask that you read the study information below, to ensure that any decision to 
participate is right for you. 
 
What is the study about? 
The study is concerned with how we feel about ourselves during treatment for any cancer.  
How we feel about ourselves can affect how we are able to live our lives or behave.  Some 
people can find that they experience difficult feelings, such as guilt, shame, or disgust about 
themselves, throughout the course of their cancer treatment.   
People who experience difficult emotions about themselves can, at times, think of 
themselves in negative ways and can also feel that others avoid them as a result.  I am 
interested in the personal stories of people who have experienced these emotions at any 
point within their cancer treatment journey. 
 
Why have I been approached? 
You have been approached because the study requires information from people who: - 
 
• have experienced difficult emotions about themselves (described above) 
• are over the age of 18 
• are no longer in active treatment for cancer. 
 
Do I have to take part? 
No.  It’s completely up to you to decide whether or not you take part.  The researcher is 
completely independent from any organisation involved in your care and your decision 
whether or not to take part will not affect any services you receive in any way.  If you do 
decide to take part, but then change your mind, you can withdraw from the study up to the 
point when the research is written up ready for submission. 
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What will I be asked to do if I take part? 
If you decide you would like to take part, you would be asked to take part in an interview at 
a time and date and venue to suit you.  I will ask if you have any special requirements before 
the interview to make your experience comfortable.  The interview will be recorded, with 
your permission, on a dictaphone and will usually last around 60 minutes.  You will be asked 
to share your story about your experience of emotions throughout your cancer journey.  It 
will be up to you to decide how much or little you would like share.  At the end of the 
interview you will have a chance to ask questions and feed back your experience of the 
interview. The interview will then be typed up by the interviewer.  Any information that 
could lead yourself or others being identified will be anonymised.   
 
Will my data be identifiable? 
The information you provide is confidential. Direct quotes from participants in this study 
may be used when it is written into a report. The source of the quote will not be attributed 
to you.  The interview will be turned into a written account and will be stored securely and 
only the researchers conducting this study will have access to it: 
o Audio recordings will be destroyed and/or deleted once the project has been 
submitted for publication/examined.  
o The computer files will be encrypted (that is no-one other than myself will be able to 
access them) and assess to university computers will be password protected.   
o At the end of the study, electronic copies of transcripts will be kept securely for ten 
years. At the end of this period, they will be destroyed.  
o The typed version of your interview will be made anonymous by removing any 
identifying information and replacing your name with a pseudonym of your 
choosing.  Anonymised direct quotations from your interview may be used in the 
reports or publications from the study.  If this happens, a pseudonym name will be 
attached to them. 
o All your personal data will be confidential and will be kept separately from your 
interview responses. 
 
There are some limits to confidentiality: if what is said in the interview makes me think that 
you, or someone else, is at significant risk of harm, I will have to break confidentiality and 
speak to my supervisor about this.  This will be discussed with you, though. 
 
What will happen to the results? 
The results will be summarised and reported in a dissertation/thesis. The results of the 
research may be submitted for publication in an academic or professional journal.  A 
summary of the results will be made available for participants who would like these. 
 
Are there any risks? 
There are no risks anticipated with participating in this study.  However, if you experience 
any distress following participation you are encouraged to inform the researcher and 
contact the resources provided at the end of this sheet. 
 
Are there any benefits to taking part? 
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Although you may find participating interesting, there are no direct benefits in taking part.  
However the information from this study may lead to benefit others who face the cancer 
journey and health professionals working with people also affected. 
Who has reviewed the project? 
This study has been reviewed and approved by the Faculty of Health and Medicine Research 
Ethics Committee, at Lancaster University. 
 
Where can I obtain further information about the study if I need it? 
If you have any questions about the study, please contact the main researcher: 
 
Selane Rigby    Tel:  xxxxxxxxxxxxx 
Email: s.rigby1@lancaster.ac.uk 
Faculty of Health and Medicine  
(Division of Health Research)  
Lancaster University  
Lancaster  
LA1 4YG 
 
Complaints  
If you wish to make a complaint or raise concerns about any aspect of this study and do not 
want to speak to the researcher, you can contact:  
 
Professor Bill Selwood    Tel: (01524) 593998  Email: b.sellwood@lancaster.ac.uk 
Doctorate in Clinical Psychology Programme Director        
Division of Health Research 
Faculty of Health and Medicine  
Lancaster University  
Lancaster  
LA1 4YG 
 
If you wish to speak to someone outside of the Division, you may also contact:  
 
Professor Roger Pickup    Tel: +44 (0)1524 593746     Email: r.pickup@lancaster.ac.uk 
Chair of the Faculty of Health and Medicine Research Ethics Committee   
Faculty of Health and Medicine  
(Division of Biomedical and Life Sciences)  
Lancaster University  
Lancaster  
LA1 4YG 
 
Thank you for taking the time to read this information sheet. 
 
Resources in the event of distress 
Should you feel distressed either as a result of taking part, or in the future, the following 
resources may be of assistance: 
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Contact your GP or Health Care Professional who works with you.  You may wish to contact 
MIND (available Monday to Friday, 9am to 6pm) 0300 123 3393 or visit www.mind.org.uk. 
Or Macmillan Cancer Support (available Monday to Friday, 9am-8pm) 0808 808 00 00 or visit 
www.macmillan.org.uk.   Alternatively, you can contact regional cancer charities and 
support groups, Cancercare on 01524 381820 (24 hour answer service) or visit 
www.cancercare.org.uk, The Rosemere Foundation Trust on 01772 522 913 or visit 
www.rosemere.org.uk, and Gentle Approach on 01772 865024 or visit 
www.gentleapproach.org.uk. 
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The thematic synthesis contained in the literature review section explores the many 
emotional experiences involved in cancer treatment at specific transition points within the 
individual’s journey.  The findings synthesised within temporally sequenced framework, 
based on transition points throughout the journey: Being diagnosed and facing treatment; 
Getting rid of cancer; Changed body and stigma; Reflections on the emotional journey having 
completed treatment.  The emotional experience changed rapidly at diagnosis, followed by a 
period of fewer and more stable emotions during treatment. The period post treatment 
signalled anger and sadness associated with loss.  Finally, life after cancer demonstrated 
emotional reconciliation and benefit finding. 
The research paper specifically investigates self-conscious emotions and both their 
evolution over time and their impact on sense of self.  Four temporally ordered acts emerged 
that provided demonstrations of self-directed difficult emotions of disgust, guilt, shame and 
fear and how and when these emotional experience changed the self. 
The findings from both papers overlap in the sense that emotional experiences are 
complex and nuanced.  Many factors, such as relationships, current stressors, past experiences 
and resources (personal and systemic) can impact on emotional experiences.  Moreover, not 
only are emotional experiences numerous and nuanced, the theories, and indeed the methods 
by which emotions can be studied, are complex.  This paper offers a discussion around some 
of the considerations and insights involved in the research of emotions, in relation to my 
research studies and the study of emotions more widely.  It also outlines some of the strengths 
and weaknesses of the research presented, in light of this discussion. 
One of the main issues relating to studying emotion has been a lack of consensus 
about what constitutes an emotion and the nature of emotion (Lupton, 1998).  For example, 
Ekman (1992) proposed a biologically driven theory identifying six basic emotions 
(happiness, fear, anger, sadness, disgust, sadness and surprise).  However, other theorists 
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suggest that there are many more emotions, although these are generally thought to be 
combinations of the aforementioned basic emotions, for example, contempt is a blend of 
anger and disgust (Plutchik, Kellerman, & Conte, 1979).  In contrast other theories, grounded 
in a social constructionist epistemology, such as situationism, suggest that emotions are 
founded and produced at a societal and environmental level and are used for skilful social 
communication (Griffiths & Scarantino, 2005).   
Obviously, lack of agreement regarding emotions and their nature has further 
implications for research methodology, particularly, for more positivist approaches that prefer 
measurement and objectivity.  Beyond measurement of specifically defined emotions, 
positivist approaches can be somewhat limited in considering social variables. In this regard, 
emotions can be viewed as elusive and complex, as they do not lend themselves to more 
traditional research methods, such as experimental designs (Zembylas, 2007).  In contrast, 
social constructionist methodology, which privileges societal factors in the construction of 
emotions, such as political and cultural norms, run the risk of not considering an individual’s 
embodied experience.  As a result of the many theoretical and methodological approaches to 
the study of emotions, the naive researcher, in which category I would include myself, should 
perhaps proceed with caution.  In particular, this caution pertains to how much we can risk 
neglecting in the research of emotions should we choose one approach to emotion research 
over another.  Indeed, how much we can learn by only pursuing one approach and thereby 
accepting a narrow perspective, might be considered reductionist in itself, regardless of 
epistemological stance.  However, even the naïve researcher must proceed, despite difficulties 
in researching emotions, particularly as emotion is viewed as a key part of what it is to be 
human.  Denzin, (1984) makes this point eloquently:  
Emotionality lies at the intersection of the person and society, for all persons are 
joined to their societies through the self-feelings and emotions they feel and 
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experience on a daily basis. This is the reason the study of emotionality must occupy a 
central place in all the human disciplines, for to be human is to be emotional.  (p. x) 
In consideration of the many complexities involved in the study of emotions, not least 
how to transcend existing dichotomies (mind or body, feeling or meaning), the task of 
operationalising emotional phenomena or experiences is a difficult one.  For example, it is 
unlikely that participants in interview scenarios would express their emotional experiences in 
terms of the six basic emotions.  Instead, interviews rely on emotional expression to be 
conveyed through common parlance that is likely to be culturally and contextually informed, 
(although not only socially driven).  In this context emotional experience is likely to be 
conveyed not just through language, but through bodily expression (crying, closing eyes, 
shaking, etc.).  Furthermore, others discursive devices, such as metaphors and comparisons, 
are likely be used to convey emotional experiences.  For example, in my own research painful 
emotions were eluded to through relaying a comparatively similar event, with a different 
outcome.  Dave told me about an event that happened shortly after the death of his wife: 
And just within 2-3 months the dog became really ill and had cancer, and was really 
sort of terminal.  It was bad.  And I had make the decision, you know, to have her put 
down, you know.  And er, I said I'm not taking her to the vets.  And I won't.  And I 
paid for the vet to come here [home], because I couldn't do it for my wife to be here at 
home, she had to die in hospital, so I'm not going to do it for her dog.  So the vet came 
and all the family came round and he dealt with her here.  Which was better for all of 
us really.  At least we could do something.  Because we all loved the dog and as I say, 
it was my wife's dog mainly so.  Yeah so that was…Yeah, because it's not pleasant to 
see somebody die in hospital, you know.  You'd rather it be in their own surroundings 
if possible, but I wasn't able to do that.  
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Within the passage, Dave finds it easier to talk about a situation in which the subject of dying 
was still at the centre, but for which Dave was able to control the setting and contribute to 
what he had considered to be a dignified death.  Many actions within the narratives required 
interpretation, in order to illustrate the underlying emotions.  For example, Dave’s actions 
may indicate feelings of guilt, at not being able to provide the environment he had wished his 
wife had at her passing.   
Interpreting underlying emotions from the narratives leave the analysis open to 
criticism concerning credibility.  Certainly the construction of the act and responsibility for 
the analysis, including which parts of the narratives to incorporate within the findings and 
how this discourse is interpreted, can indeed be viewed as subjective.  In fact, the analysis 
should be viewed as co-constructed and therefore subjective.  In part, the subjectivity of the 
analysis, providing that it is acknowledged, may be viewed as a strength and this may be 
particularly so in the research of emotions.  This is because one of emotion’s most likely 
functions is communication therefore emotions felt by the researcher in the relational 
interplay may equally offer insight into participants’ emotional experience.  Indeed, some 
researchers use the term ‘hidden ethnography’ to refer to emotions evoked in researchers, 
particularly when investigating difficult topics.  However, the ‘hidden’ aspect relates to 
research conventions either not accommodating or actively prohibiting the emotional 
experience of the researcher to be incorporated into the completed research (Blackman, 
2007).  In contrast, Lee-Treweek and Linkogle (2000) conclude: ‘the emotions of research are 
important to both the researcher’s ability to cope and the quality of the account they produce. 
Ignoring or repressing feelings about research is more likely to produce distortion of data, 
rather than clarity’ (p. 128).  Punch (2012) goes further, suggesting that the use of extracts 
from field diaries that record the emotions and feelings of the researcher be explicitly 
incorporated into research.   
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Certainly, within my own research journey, the parts of my participants’ interviews 
that I recall the best are those that evoked an emotional reaction from me.  For example, 
Hazel, who had had a laryngectomy – the removal of her voice box - requested that I record 
her voice before we start the interview in order that she could assure herself that the recorder 
would be able to pick up her speech.  I recall two key moments within this interaction.  
Firstly, her bodily reactions upon listening back to her recorded voice.  Secondly, her asking 
me ‘Do I really sound like that?  It’s awful’.  Both of these events were ones in which I felt 
Hazel’s disgust at the sound of her own voice, particularly her bodily reactions to hearing her 
recorded voice in which she closed her eyes and put her hand to her mouth (a classic disgust 
behavioural response).  Clearly, these events were beyond capturing in the voice recording 
and subsequent transcription process.  However, my experience alerted me to Hazel’s 
underlying emotions regarding her voice.  My own emotional experiences with Hazel and 
other participants throughout my research, influenced how I interpreted the narratives.  In this 
respect, the analysis of the narratives not only allows us to see emotions in the context of 
what has caused them, how they are experienced (both felt and embodied), and subsequent 
actions, but also as a co-construction in which the emotions of the researcher to the material 
are illustrated. 
Moreover, researching difficult emotions, and in particular disgust, may have taken on 
a taboo of its own, not unlike the reactions encapsulated by the disgust response.  Certainly, 
in different fields and perspectives, disgust takes on different forms and means.  For example, 
in the field of academia the understanding and meaning of disgust takes it underpinnings from 
definitions, such as that offered by Rozin and Fallon (1987), who clarify disgust as: 
‘revulsion at the prospect of (oral) incorporation of an offensive object. The offensive objects 
are contaminants; that is, if they even briefly contact an acceptable food, they tend to render 
that food unacceptable’ (p.23).  However, within the general population the word disgust has 
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been found to be more synonymous with anger, with the lay person’s term ‘grossed out’ a 
closer match to the theoretical meaning of disgust (Nabi, 2002). 
Moreover, the interest in disgust, which can often be an adaptive response to stimuli 
from a researcher’s perspective, does not always hold the same meaning both within the 
general and, more specifically, the cancer population.  In fact, during the course of my own 
research, while in communication with a cancer charity, I received the following email in 
response to sending them the study information materials: 
The following is offered for information only, and is offered from a lay person - albeit 
from someone who has worked very closely with cancer patients over more than 15 
years – so has no psychological credentials behind it. 
Some of the language used by researchers can sometime be a barrier to participation 
in research. Last year we had agreed (with the Group) that a researcher was going to 
do some work with the Group that meets at our …around three times a year for blocks 
of yoga sessions. Unfortunately after the first session with the Researcher within the 
Group, we found that we lost a number of the participants in the Yoga Group. The 
week after even more decided not to come and we were informed that there would be 
even less if this continued. So we halted the research. 
I say this as one of the words that was being used within that research and which 
seemed to be unhelpful was “disgust” and “self-disgust”. This is a really strong word 
and whilst may in fact be an accurate indicator of what someone is feeling, can be 
difficult for people to acknowledge – especially when they are “surviving” and trying 
to remain positive. 
Indeed, this gives much food for thought, particularly if disgust or self-disgust ‘can be 
difficult for people to acknowledge’.  Incorporating this feedback into my own research 
brought with it many tensions.  Primarily, how was disgust or self-disgust going to be brought 
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out in the narratives, particularly as a narrative approach offers the narrator (participant) the 
space to tell their story in their own terms, and therefore, they are unlikely to use the word 
disgust by choice.  In order to navigate this particular tension, the narratives relied on my 
interpretations based on my knowledge of how emotions, such as disgust, may present 
themselves in actions and cognitions, as these were more likely to be represented in the 
participants’ language than naming the underlying emotion per se. 
Furthermore, inferred in the email were themes of ‘positive psychology’ and what is 
permitted in cancer recovery, in particular, ‘remaining positive’.  Ideas of ‘positive thinking’ 
have permeated cancer care since the 1990’s (e.g. Gray & Doan, 1990) and form part of the 
current dominant narrative among the cancer community (McCreaddie, Payne & Froggatt, 
2010).  However, positive thinking is not without its critics, most notably Wilkinson and 
Kitzinger (2000), who take a social constructivist perspective on the issue of positive thinking 
in cancer.  They suggest that people make meaning through their understanding of the ‘rules’ 
within a social context, and go on to infer that although an individual may say that they are 
‘thinking positively’, that does mean that they do think ‘positively’, rather these are echoes of 
the inferred rules of group or social membership.  Understandably then, a researcher 
interested in difficult emotions, which could be conceived as representing potentially 
‘negative thinking’ and therefore in contradiction of the social rules, is likely to receive a 
lukewarm response. 
 Moreover, would the narratives in my own research be peppered by ‘positivity’ talk 
that conforms to the current dominant discourse of cancer recovery?  Indeed, there was some 
evidence of positive thinking within the narratives. Here a participant talks about their cancer 
recovery citing the need to obtain a ‘positive attitude’:  
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I wasn't powerless. I couldn't do anything about the cancer, obviously that was the 
surgeons, but I could do something about getting fit again, and getting a positive 
attitude to it and dealing with the physical side of chemo and everything.  
Obviously, the acceptability and dominance of positivity adds an additional layer when 
attempting to uncover more difficult emotions within the narratives.  The point here is not 
that people do not feel positive, indeed in my own literature review, as in other studies (e.g., 
post-traumatic growth, Foley et al., 2006), many participants cited a renewed sense of self, 
but if the dominant discourse only allows for positive thinking, this may result in 
marginalising people who are unable to embody this mind set.  In this regard, research that 
seeks to explore difficult emotions is not only timely but relevant, given that marginalised 
groups are those more likely to require support.   
 From the beginning of the research process, difficult emotions, again with particular 
focus on disgust, raised many concerns.  Ethical considerations around the practicalities of 
researching disgust were prevalent and took on a number of forms.  Initially, the definition 
used in the participant information sheet took on elements from the Self-Disgust Scale 
Revised (SDS-R) (Powell, Overton & Simpson, 2014) and read as follows: 
One emotion of particular interest is that of disgust, which has been identified as 
potentially both a cause of psychological distress during cancer treatment and a 
reaction to the treatment.  People who experience feelings of disgust can find 
themselves repulsive, can’t stand being themselves, or think that they are revolting for 
many reasons.  People who feel this way about themselves can also feel that others 
avoid them, as a result. 
However, due to concerns around the definition of disgust, in particular, not appealing to 
participants, the following definition was adopted: 
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The study is concerned with how we feel about ourselves during treatment for any 
cancer.  How we feel about ourselves can affect how we are able to live our lives or 
behave.  Some people can find that they experience difficult feelings, such as guilt, 
shame, or disgust about themselves, throughout the course of their cancer treatment.   
People who experience difficult emotions about themselves can, at times, think of 
themselves in negative ways and can also feel that others avoid them as a result.  I am 
interested in the personal stories of people who have experienced these emotions at 
any point within their cancer treatment journey. 
Understandably and rightly, part of the research ethics committee’s role is to ensure that 
research projects are viable.  Indeed, the ethics committee made many helpful suggestions in 
order for study participation to be attractive.  However, the more diluted version of the study 
definition (i.e. putting disgust within a string of other self-directed but less visceral emotions) 
had the impact of changing both the initial focus of the project, that of self-disgust, to difficult 
emotions more generally.  Additionally, the amended version of the definition was more open 
to interpretation and, therefore, less targeted and ran the risk of participants taking part in 
study that did not necessarily match the study focus.  
 Moreover, other projects interested in the exploration of self-disgust have been able to 
use instruments, such as the SDS-R for quantitative studies, or to screen participants for 
qualitative projects.  However, because of the research question and design, the participants I 
was interested in interviewing did not need to be currently experiencing self-disgust, but had 
needed to have experienced it at some point in their cancer journey.  The SDS-R is sensitive 
to recent or present indicators of self-disgust, not to past (and now irrelevant) experiences of 
self-disgust, therefore rendering this instrument redundant as a screening tool.  Again, use of 
a strong study definition and, therefore, correct participant interpretation of the nature of the 
study, was of paramount importance in order to attract people who had experienced self-
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disgust.  However, as the study definition and therefore focus of the study had changed, it 
could not be assumed that participants had experienced self-disgust per se, rather the type of 
difficult emotions experienced needed to be teased out during the interviews.  Clearly, not all 
participants had experienced self-directed disgust, which therefore changed the shape and 
direction of the study somewhat. 
 However, the narratives gained as a result of the study definition offered a great deal 
of insight into the nature and experience of self-directed difficult emotions, within the cancer 
journey.  It is interesting to note that participants experienced similar processes and 
treatments, however, individual differences in how these are experienced, interpreted and 
appraised provides much insight into the richness and variation involved in emotions and 
their experience.  Indeed, far from detracting from the focus of the research, the breadth and 
depth in the narratives provided indicators and demonstrations of not just when and how 
difficult emotions are experienced, but how and when they are overcome and, at times, how 
they can endure.  Therefore, both the narratives illustrated within the research project and the 
literature review offer an insight into the variation, complexity and nuance of the emotional 
experiences during cancer and treatment processes, signposting future research and clinical 
directions.  
 In terms of clinical implications resulting from the papers, there are numerous 
indicators that health professionals need to assess and consider individual contextual factors 
before offering interventions.  My research findings demonstrated that emotional experiences 
can evolve overtime, however, guidance focused on the management of distress that indicate 
early identification and intervention from the point of diagnosis, can run counter to these 
findings.  Obviously, it is important to identify people who would benefit from support and 
interventions, but if a broad brush approach is taken, there is a risk of disrupting natural 
coping mechanisms (Baker et al., 2013).  Moreover, more targeted and individualised 
RESEARCHING EMOTIONS                        3-12 
 
assessment may also have the benefit of reducing unnecessary referrals of clinical support.  
For example, Dennis told me: 
They sent me to see a Clinical Psychologist...There was two of us me and this young 
lady.  She had cancer.  And we were both seeing the same rheumatologist.  And he got 
this idea into his head, that if you had cancer, you must be depressed.  So he referred 
us to this Clinical Psychologist and we laughed because we both got a letter saying we 
weren't depressed. 
Clearly, a nuanced approach to assessment of those undertaking cancer treatment, which 
considers emotional transitions points within the cancer treatment journey and individual 
factors, such as current stressors and resources, needs to be adopted.   
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Due to the small sample size, even after full anonymization there is a small risk that participants can be 
identified. Therefore, supporting data will only be shared on request with academic researchers.  Access will be 
granted on a case by case basis by the Research Supervisor or Head of Department of the Faculty of Health and 
Medicine. 
 
9. Consent 
a. Will you take all necessary steps to obtain the voluntary and informed consent of the prospective 
participant(s) or, in the case of individual(s) not capable of giving informed consent, the permission of a legally 
authorised representative in accordance with applicable law?  yes 
 
b. Detail the procedure you will use for obtaining consent? 
Consent to participate will be gained via the completion and signing of a study consent form.  In the event of a 
telephone interview, consent will be gained verbally and recorded via voice recorder. 
 
10. What discomfort (including psychological eg distressing or sensitive topics), inconvenience or danger could 
be caused by participation in the project? Please indicate plans to address these potential risks. State the 
timescales within which participants may withdraw from the study, noting your reasons. 
 
Current literature suggests the people who have cancer show high prevalence rates of psychological distress 
(e.g. Zabora, BrintzenhofeSzoc, Curbow, Hooker, & Piantadosi, 2001).  It is possible therefore, that sharing the 
story of their journey through cancer treatment has the potential to cause distress. 
Participants will be informed and reminded that they can stop the interview at any time. The researcher, as a 
Trainee Clinical Psychologist, has developed skills in containing people in immediate distress as part of their 
training. However, no therapy will be take place between the researcher and participants.  Participants will also 
be signposted to services if appropriate and contact details made available as part of the study debrief (see 
study information sheet). 
Participants will be made aware in the consent form that they are free to withdraw at any time up until March 
2017, as the analysis and write up will be completed and draft read by this point. Before this point the 
interviewee will be free to withdraw without giving reason or negative consequences. 
Before the start of the interview, interviewees will be asked about their preference of action, should they 
become upset.  This may include having break, rescheduling, or contacting someone for them. 
Participants will be signposted to services if appropriate and contact details made available as part of the study 
debrief.  Debriefing will take place at the end of the interview when the participant about their experience of 
the interview and given the opportunity to ask any questions.  National support numbers will be provided. 
Confidentiality will be ensured, unless there is disclosure of information that suggests somebody is at risk of 
serious harm. In this case advice from my research supervisor will be sought. Participants will be made clear of 
this verbally and within the study information sheet.      Page 5 
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11. What potential risks may exist for the researcher(s)? Please indicate plans to address such risks (for 
example, noting the support available to you; counselling considerations arising from the sensitive or 
distressing nature of the research/topic; details of the lone worker plan you will follow, and the steps you will 
take). 
The Lancaster University’s Lone Work guidance will form the basis of the plans to address field working 
risks.  In particular Section 5 of the code of practise for work on campus and fieldwork and personal safety 
off campus will be followed when lone working.  See pages 44-46 of 
http://www.lancaster.ac.uk/depts/safety/files/Fieldwork.pdf. 
When interviewing off campus:- 
1.Upon arrival at the premises the Researcher should phone a designated contact (course colleague or family 
member) from outside the premises to assure them they have arrived safely and that the phone is working. 
Contact should be maintained at specified time intervals. If the Researcher decides that the designated 
person is a household member or friend this would be agreed with the Supervisor, as it is the University who 
is responsible for ensuring the Researcher’s safety. 
2. An emergency plan should be developed for situations where contact is not maintained or return times are 
missed. This would be to contact the University department.  The name and address of the person the 
researcher is scheduled to meet will be left in a sealed envelope with the designated contact, only to be 
opened in the event of an emergency and once contact is made with the department (Either by main 
department switchboard or out of hours mobile phone). If the department cannot be contacted the police 
should be contacted and their advice followed. 
 3. Researchers are given information from previous interviews where relevant. 
 4. If Researchers are concerned about a visit in advance then, they will arrange to be accompanied or 
to be phoned during the visit. 
12. Whilst we do not generally expect direct benefits to participants as a result of this research, please state 
here any that result from completion of the study:   There may be no direct benefit to participation in this 
study. However participation in the research may be a positive experience as the study may benefit others 
who face the cancer journey and health professionals working with this population. 
13. Details of any incentives/payments (including out-of-pocket expenses) made to participants: Some 
travel expenses in terms of mileage may be required for any interview attendance.  These are expected 
to be minimal as participants are likely to live in the vicinity of the interview venue, which is likely to be 
the place in which the interviewee's support group takes place, or within the participant's home. Travel 
costs up to the maximum value of £10 will be reimbursed by Lancaster University DClinPsy. 
14. Confidentiality and Anonymity 
a. Will you take the necessary steps to assure the anonymity of subjects, including in subsequent 
publications?  yes 
Please include details of how the confidentiality and anonymity of participants will be ensured, and the 
limits to confidentiality.  Participants will be given the option of choosing a pseudonym, having a 
pseudonym assigned by the researcher, or retaining their own name, as retaining their own name which 
can prevent ‘loss of ownership’ (Grinyer, 2002). Participants who choose to retain their own name, will be 
reminded that this may make their interview data more identifiable and given the option to reconsider. If 
an inappropriate name is chosen, the participant will be informed that its use in the study write up may not 
be guaranteed and will be decided by the research supervisors. The option to generate an alternative 
name, in the event that the original pseudonym is not permitted, will be given.  Transcription will be carried 
out by the researcher. References to individuals or organisations during the recording of the interviews will 
be anonymised during the transcription process. Confidentiality will be ensured, unless there is disclosure 
of information that suggests somebody is at risk of serious harm. In this case advice from my research 
supervisor will be sought. Participants will be made clear of this verbally and within the study information 
sheet. 
         Page 6
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15.  If relevant, describe the involvement of your target participant group in the design and 
conduct of your research. 
 
A service user, who currently meets the target cancer participation criteria, has provided feedback 
on the study materials.  However, there has not been direct involvement from the target group in 
the design and conduct of the research. 
 
16. What are the plans for dissemination of findings from the research?  If you are a student, 
include here your thesis. 
 
The initial mode of dissemination will be via Doctoral Thesis. The research team involved in this 
work and those examining it, will be privy to the results. The results of the research will be 
submitted for publication in an academic/professional journal and, as a result, may be published.  
A summary of the story will be made available for participants who would like these. Findings may 
also be presented at applicable conferences 
 
17. What particular ethical considerations, not previously noted on this application, do you think 
there are in the proposed study?  Are there any matters about which you wish to seek guidance 
from the FHMREC? 
 
The participants may give negative comments on treatment they have received or an organisation 
that they have been recruited through.  Although this is not expected, nor does it form the basis of 
the research, the breath of experiences that the participant may choose to cover as part of their 
own narrative and sense of self may include many and varied aspects of their cancer journey.  
Reassurance will be offered as to the neutrality of the interviewer, the usefulness of all parts the 
participant’s story related to the topic and that anonymity will be maintained. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Page 7 
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Thesis Research Protocol 
 
Doctorate in Clinical Psychology 
 
 
 
 
 
 
 
Title: The role of difficult emotions in the cancer treatment journey 
 
Researcher: Selane Rigby 
 
Research Supervisors: Dr. Jane Simpson (Lancaster University) and Dr. Philip Powell 
 
(University of Sheffield) 
 
Date: 21st November 2016
ETHICS                                                                                                                                                             4-10 
 
 
 
Self-disgust as a psychological concept is difficult to define, although features unique 
to disgust can be used to distinguish self-disgust from other closely-related affective 
phenomena in the general population.  However, theoretically self-disgust can be viewed as 
an emotional schema by which disgust is directed towards the self and, if enduring, can have 
negative consequences for a range of mental health and behavioural outcomes (Powell, 
Simpson, & Overton, 2014). Furthermore, due to the infancy of the concept of self-disgust, 
there is a dearth of literature exploring the role of disgust directed at oneself in people with 
long-term physical health conditions. 
 
Much of the research on self-disgust to date is concentrated in mental health. For 
example, self-disgust has been hypothesized to function as an antecedent to the depressive 
experience and play a role in depression (Overton, Markland, Taggart, Bagshaw, & Simpson, 
2008).  However, self-disgust may also persist in the absence of depressive experience 
(Powell, Overton, & Simpson, 2014).  Moreover, it is likely that physical aspects of oneself 
can activate self-disgust (Reynolds, McCambridge, & Consedine, 2015).  Furthermore, 
physical symptoms of ill health, as well as the effects of treatment, have the potential to 
active the self-disgust schema, therefore in long-term physical health conditions these self- 
disgust elicitors can become commonplace and unavoidable (Reynolds, et al., 2015).  Indeed, 
recent longitudinal research suggests that self-disgust may not only partially mediate links 
between dysfunctional thoughts and depressive symptoms but that disgust towards physical 
aspects of oneself have the potential to be a more important predictor than disgust towards 
behavioural aspects of the self (Powell, Simpson, & Overton, 2013). 
 
One of the most prevalent physical health problems and a leading cause of death in 
United Kingdom is cancer.  Although incidence of cancer is rising, mortality rates are falling 
due to advancements in detection and treatments (Office for National Statistics, 2015). 
However, as with other long-term health conditions, mental health can impact on how cancer
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patients respond to treatment, (e.g. DiMatteo, Lepper, & Croghan, 2000), decide on 
treatment, adhere to treatment protocols (e.g. Reynolds, Bissett, Porter, & Consedine, 2016) 
and duration of survival (e.g. Falagas et al., 2007).  In particular, anxiety and depression 
feature most prominently in the literature, as prevalence rates among people with cancer are 
estimated to be at least double that of the general population (Hinz, et al., 2010). 
 
Moreover, recent studies using quantitative methodology has found that self-disgust is 
a mediator of psychological distress in adults with cancer (Powell, Azlan, Simpson, & 
Overton, 2016; Azlan, Overton, Simpson, & Powell, 2016).  The former study found that 
experiencing physical side-effects of cancer treatments, such as nausea, bowel and bladder 
problems, considered to be elicitors of core disgust responses, were indicative of increased 
psychological distress symptomology. Furthermore, the effect of core disgust side-effects on 
self-disgust were also moderated by one’s underlying disgust propensity (Powell, et al., 
2016).  Disgust sensitivity in cancer populations has also been found to significantly predict 
depressive symptoms over and above matched controls (Azlan, et al., 2016).  Moreover, self- 
directed disgust mediated the impact of core disgust side-effects on psychological adjustment 
to cancer treatment (Powell, et al., 2016), highlighting the relevance of self-disgust in relation 
to the cancer journey. 
 
However, the theoretical story of how self-disgust develops and changes throughout 
the course of cancer treatment is as yet unexplored.  Indeed, the experience of self-disgust 
over the course of any health condition has yet to be the subject of research investigation. 
Given the role of self-disgust in avoidance and/or protection, its potential impact on 
interactions with treatment and psychological wellbeing and therefore recovery are important 
to consider.
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Furthermore, due to the rejection responses of oneself and schematic appraisal driven 
by self-disgust, it is likely that the rejection of others may also be anticipated, leading to 
social withdrawal in order to avoid the expected rejection from others.  Therefore, it is 
suspected that self-disgust may be an important mechanism underpinning the social 
withdrawal common in adaption to long-term physical health conditions, including cancer 
(Reynolds, et al., 2015). 
 
As self-disgust is a relatively new research topic, little guidance is available to 
clinicians working within long-term physical health conditions generally.  Indeed although 
current theories of self-disgust highlight negative implications, such as avoidance, self- 
disgust as a protective mechanism is even less well understood in a physical health context. 
Moreover, given the original role of disgust in the protection from threats to health, physical 
health maybe a context in which self-disgust may also be beneficial, for example, in 
encouraging wound self-management and wound care treatment (Gaind, Clarke, & Butler, 
2011). 
 
 
Consequently, the primary aim of this study is to investigate the role of self-disgust, 
as a self-conscious emotion, throughout the course of cancer treatment.  The evidence from 
personal narratives can highlight when the self-disgust is most prominent within the cancer 
treatment journey and, equally importantly when and how self-disgust becomes more 
dormant (in line with its conceptualisation as an emotion schema).  Moreover, a greater 
understanding of the psychological trajectory of self-disgust in people who have had cancer 
will provide guidance to health care professionals working with this population.  The specific 
research question for this study is: what are the narratives of self-disgust in individuals who 
have experienced treatment for cancer?
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Participants 
Method
 
 
Participants will be adult age (18 years or older) who have had a cancer diagnosis (any) 
but are no longer in active treatment (i.e. radiotherapy/chemotherapy).  Information on 
participant demographics will be collected and will include age, gender, ethnicity, primary 
cancer diagnosis, type and duration of cancer treatment, age of onset and time elapsed since 
active treatment. 
 
Inclusion Criteria. 
 
 
1.   Participants will be adults (18 years and above) at the time of interview. Although 
may have been younger at the time of treatment. 
2.   Participants will identify with having experienced self-disgust (from the study 
information sheet and/or study advertisement description) at some point throughout 
the course of their cancer journey/treatment. 
 
 
 
Exclusion Criteria. 
 
1.   Participants cannot have a ‘watch and wait’ tumour diagnosis. 
 
2.   Participants will not be in active treatment (i.e. radiotherapy/chemotherapy) when 
they are interviewed but could be on less invasive treatments (e.g., hormone therapy 
with tamoxifen). 
3.   Non English speaking as this type of analysis (narrative) requires the speaker and 
interviewer/researcher to be fluent in the same language.
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Sample 
 
 
The intended number of participants will be up to 15 people in order to obtain enough 
data for chapters of the self-disgust story in cancer to emerge.  This is in line with published 
research using narrative methods (e.g., Simpson, Heath & Wall, 2014). 
 
An open approach to the sampling will be adopted initially.   In the event that more than 
 
15 expressions of interest are received, a purposive approach will be triggered.  Purposely 
sampled participants will be selected based on variety of experiences and backgrounds, in an 
attempt to best represent a wide variety of perspectives. 
 
 
 
 
 
Design 
 
 
This is a qualitative study using narrative analysis to analyse data from one to one 
interviews involving up to 15 participants.  The participants will be recruited via a study 
information sheet given to people who have expressed an interest in the project. Potential 
participants will have involvement/support from a regional cancer charity and identify 
themselves as having experienced self-disgust/self-conscious emotion, either during or after 
their cancer experience, prior to being interviewed from the definition given in the study 
information.   Participants interested in taking part in the study will contact me to arrange an 
interview time and date.  Data will be maintained by the researcher in order to ensure fidelity, 
validity and reflexivity.
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Procedure 
 
 
Recruitment. 
 
 
Participants will self-identify as having experienced self-disgust prior to being 
interviewed from the definition contained in the participant information sheet and study 
advertisement.  They will be recruited from the community and will have been treated for at 
least one form of cancer.  Regional cancer charities and support groups such as 
xxxxxxxxxxxx will be contacted by the lead researcher using a university telephone or email 
account.   The organisation will be provided with a participant information sheet if initial 
contact is via email, or forwarded via email after an expression of interest on telephone 
contact.  Any other information they wish to review, i.e. ethical approval before promoting 
the study, will be sent via university email. If the organisation consents to advertising the 
study, all necessary materials will be sent.  The promotion of the study by consenting 
organisations can be done via electronic media 
channels such as social media, website, email and online forums, as well as more traditional 
routes such as newsletters, word of mouth and notice boards.  The advertisement and 
participant information sheet will contain the contact information of the researcher 
(university email and telephone) and will ask potential participants to contact the researcher 
directly. 
 
Once contacted, the researcher will answer any questions potential participants may 
have about the study and, if agreeable with the participant, arrange a time and place for an 
interview to take place.  Interviews will take place at participants’ homes, a room on the 
university campus or a venue in the community, according to the participant’s preference. 
The Lancaster University lone working guidance will be followed, with particular reference
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to Section 5 of the code of practise for work on campus and fieldwork and personal safety off 
campus.  As a last resort, telephone interviews will be offered and arranged. 
 
Consent. 
 
 
Consent to participate will be gained via the completion and signing of a study 
consent form.  In the event of a telephone interview, consent will be gained verbally and 
recorded via voice recorder. 
 
Interview. 
 
 
Given the nature of narrative analysis, in that it is interested in individuals’ personal 
perspectives of their own story and sense of self by allowing space for the narrative to evolve, 
the interview will be mainly unstructured and will begin by asking the main question; an 
invitation for participants to talk about their experience of difficult or self-conscious 
emotions, throughout their cancer journey.  However in order to maintain the focus of the 
research question, the researcher may ask questions to clarify a point, or to expand on an area 
of interest, from a neutral position. The interviews will be audio recorded and transcribed by 
the researcher.  A transcript of their interview and summary of the story will be sent to 
consenting participants, once the study has been submitted for assessment. 
 
Analysis. 
 
 
Narrative analysis will be used to analyse the interview data.  This type of analysis 
places emphasis on the interplay between self and context.  The core element of this type of 
analysis is the uncovering of the self-construct, in particular how participants view 
themselves and how this view is shaped.  Furthermore, it focuses on the process of shaping 
and the contributing factors (Weatherhead, 2011).  This is a useful approach for answering
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the research question, in that is allows for in-depth exploration of the development of self- 
disgust as part of the view of self, throughout the cancer treatment journey. 
 
Confidentially. 
 
 
Participants will be given the option of choosing a pseudonym, having a pseudonym 
assigned by the researcher, or retaining their own name which can prevent ‘loss of 
ownership’ (Grinyer, 2002).  References to individuals during the recording of the interviews 
will be anonymised during the transcription process. The interview recordings will be 
transported and stored securely.  The recordings will be uploaded to Box at the earliest 
opportunity and deleted from the recording device. 
 
Demographics will be collected from the recorded data and stored electronically in a 
password protected file on the Lancaster University server, Box.  Any names and contact 
details will be stored on Box in a separate password protected file and deleted once the 
summary of findings have been delivered and the study assessed. 
 
Audio files of the interviews will be stored and deleted once transcription of the 
interview has been completed.  Scanned consent sheets and typed transcripts will be stored 
electronically on Box (Lancaster University server) for 10 years.  A member of the research 
team will be responsible for deleting the files after this time has elapsed. 
 
Potential to cause distress. 
 
 
Current literature suggests the people who have cancer show high prevalence rates of 
psychological distress (e.g. Zabora, BrintzenhofeSzoc, Curbow, Hooker, & Piantadosi, 2001). 
It is possible therefore, that sharing the story of their journey through cancer treatment has the 
potential to cause distress.
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Participants will be informed and reminded that they can stop the interview at any 
time.  The researcher, as a trainee clinical psychologist, has developed skills in containing 
people in immediate distress as part of their training.   However, no therapy will be take place 
between the researcher and participants.  Participants will be signposted to services if 
appropriate and contact details made available as part of the study debrief. 
 
Timescale 
 
 
Ethics form complete – Sept 2016 
 
 
Ethics Approval – November 2016 
 
 
Data Collection – November 2016 – March 2017 
 
 
Data Analysis & Write up – October 2016 – May 2017
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Sample advertisements
 
 
 
Have you experienced difficult emotions about yourself 
during your cancer treatment journey? 
 
As a result of the experience of being diagnosed and treated 
for cancer, some people can find that they experience 
difficult feelings about themselves - feelings such as guilt, 
shame or disgust. 
 
If you have experienced these feelings, are not having active 
treatment, and are over 18 years old, I would love to hear 
your story. 
 
For more information visit *insert link to PIS*. Or please contact me 
on:- 
 
Selane Rigby   Tel: xxxxxxxxxxxxx 
Email: s.rigby1@lancaster.ac.uk 
 
Trainee Clinical Psychologist 
Faculty of Health and Medicine 
(Division of Health Research) 
Lancaster University 
Lancaster 
LA1 4YG
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Website and Social Media: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Have you experienced difficult emotions about yourself 
during your cancer treatment journey? 
 
As a result of the experience of being diagnosed and treated 
for cancer, some people can find that they experience 
difficult feelings about themselves - feelings such as guilt, 
shame or disgust. 
 
 
If you have experienced these feelings, are not having active 
treatment, and are over 18 years old, I would love to hear 
your story. 
 
For more information click here*insert organisation* page 
 
 
Or please contact me on: 
 
Selane Rigby   Tel:  xxxxxxxxxxxxx 
Email: s.rigby1@lancaster.ac.uk 
 
Trainee Clinical Psychologist 
Faculty of Health and Medicine 
(Division of Health Research) 
Lancaster University 
Lancaster 
LA1 4YG
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Twitter advert: 
Have you experienced difficult emotions about yourself during your cancer 
treatment journey?  Participants needed for a psychology study *insert 
organisation* page
ETHICS                                                                                                                                                             4-25 
 
 
Email invitation:- 
 
 
PARTICIPANTS REQUIRED 
 
 
Have you experienced difficult emotions about yourself during your cancer 
treatment journey? 
 
As a result of the experience of being diagnosed and treated for cancer, some people can 
find that they experience difficult feelings about themselves - feelings such as guilt, shame 
or disgust. 
 
If you have experienced these feelings, are not having active treatment, and are over 18 
years old, I would love to hear your story. 
 
For more information visit *insert link to PIS*. 
Or please contact me on:- 
Selane Rigby    Tel:  xxxxxxxxxxxxx 
 
Email: s.rigby1@lancaster.ac.uk 
 
Trainee Clinical Psychologist 
Faculty of Health and Medicine 
(Division of Health Research) 
Lancaster University 
Lancaster 
LA1 4YG
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Consent Form 
 
Study Title: “Understanding difficult emotions about yourself in the cancer treatment journey” 
 
We are asking if you would like to take part in a research project in order to understand the role self- 
conscious emotions throughout the cancer journey from your own personal story. 
 
Before you consent to participating in the study we ask that you read the participant information sheet and 
mark each box below with your initials if you agree.  If you have any questions or queries before signing 
the consent form please speak to the principal investigator, Selane Rigby. 
Please initial each 
statement 
 
1.   I confirm that I have read the information sheet and fully understand 
what is expected of me within this study 
 
2.   I confirm that I have had the opportunity to ask any questions and to 
have them answered. 
 
3.   I understand that my interview will be audio digitally recorded and 
then made into an anonymised written transcript. 
 
4.   I understand that audio recordings will be kept until the research 
project has been examined. 
 
5.   I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my 
medical care or legal rights being affected. 
 
6.   I understand that once my data have been anonymised, incorporated 
into a themes and written up ready for submission, I will not be able 
to withdraw. 
 
7.   I understand that the information from my interview will be pooled 
with other participants’ responses, anonymised and may be 
published. 
 
8.   I consent to anonymised quotations from my interview being used in 
reports and publications from the study. 
 
9.   I understand that any information I give will remain strictly 
confidential and anonymous unless it is thought that there is a risk of 
harm to myself or others, in which case the principal investigator 
may need to share this information with her research supervisors. 
 
10. I consent to Lancaster University keeping written transcriptions of 
the interview for 10 years after the study has finished. 
 
11. I understand that the researcher will share and discuss data with their 
supervisors. 
 
12. I consent to take part in the above study. 
 
 
Name of Participant                                     Signature                                         Date    
 
Name of Researcher                                     Signature                                         Date   
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Interview Schedule 
 
Pre-interview 
 
Gender:  M/F 
 
Age:    
 
Ethnicity    
 
Primary cancer diagnosis:   
 
Type of cancer treatment:_   
 
Duration of cancer treatment:    
 
Age of onset:   
 
Time elapsed since active treatment    
 
The interview typically lasts for around 60 minutes, but will depend on the participant and their 
information sharing.  There is no pressure to give information that you do not feel comfortable with. 
You can take breaks at any time during the interview and ask for the recording to be paused. 
 
 
 
 
 
 
You may like to talk about friends, family, or professionals in your answers and if you do it would be 
helpful to talk about them in a way that prevents them from being identified. 
 
 
 
 
 
 
Interview Questions 
Would you like to tell me about how you felt about yourself, throughout your cancer journey? 
Possible prompts – Can you tell me more about …….? How did these feelings impacted on …..?  I 
would be interest to learn more about……. if you are ok to share more with me. 
 
 
 
 
 
 
Debrief 
 
That is the end of the interview questions. Is there anything that you would like to add that you’ve 
not had the opportunity to do so? (wait for response).   Do you have any questions about the 
interview?
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EMOTIONAL EXPERIENCES OF CANCER TREATMENT 
 
 
How do you feel about having taken part in this interview? 
 
 
 
 
Contact details for xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 
 and the mental health charity MIND are available on your participant information sheet. Would you 
like to be contacted in future with a summary of the overall research results? Y/N 
If so, how would you like to be contacted?  Telephone/email:    
 
 
 
 
Thank you for your time and taking part in this study. 
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